{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## BlackSheep Cookbook Exploration\n",
    "\n",
    "The Black Sheep Analysis allows researchers to find trends in abnormal protein enrichment among patients in CPTAC datasets. In this Cookbook, we will go through the steps needed to perform a full Black Sheep Analysis."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Step 1a: Import Dependencies\n",
    "First, import the necessary dependencies and load cptac data."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import numpy as np\n",
    "import pandas as pd\n",
    "import pandas_profiling\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns\n",
    "import cptac\n",
    "import binarization_functions as bf\n",
    "import blackSheepCPTACmoduleCopy as blsh\n",
    "import gseapy as gp\n",
    "from gseapy.plot import barplot, heatmap, dotplot\n",
    "import requests\n",
    "import json"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Step 1b: Load Data and Choose Omics Table\n",
    "For this analysis, we will be looking at results across the proteomics, transcriptomics, and phosphoproteomics tables."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "All files already downloaded and correct.\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "True"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "cptac.download(dataset='endometrial')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "                                    \r"
     ]
    }
   ],
   "source": [
    "en = cptac.Endometrial()\n",
    "proteomics = en.get_proteomics()\n",
    "transcriptomics = en.get_transcriptomics()\n",
    "clinical = en.get_clinical()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "#Append Genomics_subtype and MSI_status to clinical table\n",
    "df= en.get_derived_molecular()\n",
    "clinical['MSI_status'] = df['MSI_status']\n",
    "clinical['Genomics_subtype'] = df['Genomics_subtype']"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Step 2: Determine what attributes you would like to A/B test. \n",
    "For this analysis, we will iteratively go through the various columns in the clinical dataset, to determine if any of them have trends within them for protein enrichment."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "#Create a copy of the original Clinical DataFrame and drop irrelevant columns.\n",
    "annotations = pd.DataFrame(clinical.copy())\n",
    "annotations = annotations.drop(['Patient_ID', \n",
    "                                'Treatment_naive', \n",
    "                                'Tumor_purity', \n",
    "                                'Gender', \n",
    "                                'Tumor_Site_Other'], axis=1)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Step 2a: Binarize column values"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "tumor_map = {'Tumor':'Normal_Tumor', \n",
    "             'Adjacent_normal':'Other_tumor', \n",
    "             'Enriched_normal':'Other_tumor', \n",
    "             'Myometrium_normal':'Other_tumor'}\n",
    "\n",
    "annotations['Proteomics_Tumor_Normal'] = bf.binarizeCategorical(clinical, \n",
    "                                                                'Proteomics_Tumor_Normal', \n",
    "                                                                tumor_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "country_map = {'United States':'US', \n",
    "               'Ukraine':'Other', \n",
    "               'Other_specify':'Other', \n",
    "               'Poland':'Other'}\n",
    "\n",
    "annotations['Country'] = bf.binarizeCategorical(clinical, \n",
    "                                                'Country', \n",
    "                                                country_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "annotations['BMI'] = bf.binarizeRange(clinical, 'BMI', 18, 25, \n",
    "                                      'Healthy', 'Unhealthy')\n",
    "\n",
    "annotations['Age'] = bf.binarizeCutOff(clinical, 'Age', \n",
    "                                       60.0, 'Old', 'Young')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "FIGO_map = {'FIGO grade 1':'Low_grade', \n",
    "            'FIGO grade 2':'High_grade', \n",
    "            'FIGO grade 3':'High_grade'}\n",
    "\n",
    "annotations['Histologic_Grade_FIGO'] = bf.binarizeCategorical(clinical, \n",
    "                                                              'Histologic_Grade_FIGO', \n",
    "                                                              FIGO_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "Myo_map = {'under 50 %':'under_50%', \n",
    "           '50 % or more': '50%_or_more', \n",
    "           'Not identified': 'under_50%'}\n",
    "\n",
    "annotations['Myometrial_invasion_Specify'] = bf.binarizeCategorical(clinical, \n",
    "                                                                    'Myometrial_invasion_Specify', \n",
    "                                                                    Myo_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "path_tumor_map = {'pT1a (FIGO IA)':'Not_FIGO_III', \n",
    "            'pT1b (FIGO IB)':'Not_FIGO_III', \n",
    "            'pT2 (FIGO II)':'Not_FIGO_III', \n",
    "            'pT1 (FIGO I)':'Not_FIGO_III', \n",
    "            'pT3a (FIGO IIIA)':'FIGO_III', \n",
    "            'pT3b (FIGO IIIB)':'FIGO_III'}\n",
    "\n",
    "annotations['Path_Stage_Primary_Tumor-pT'] = bf.binarizeCategorical(clinical, \n",
    "                                                                    'Path_Stage_Primary_Tumor-pT', \n",
    "                                                                    path_tumor_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "path_lymph_map = {'pN0':'Not_FIGO_III', \n",
    "                  'pNX':'Not_FIGO_III', \n",
    "                  'pN1 (FIGO IIIC1)':'FIGO_III', \n",
    "                  'pN2 (FIGO IIIC2)':'FIGO_III'}\n",
    "\n",
    "annotations['Path_Stage_Reg_Lymph_Nodes-pN'] = bf.binarizeCategorical(clinical, \n",
    "                                                                      'Path_Stage_Reg_Lymph_Nodes-pN', \n",
    "                                                                      path_lymph_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "clin_stage_map = {'cM0':'cM0_or_cM1', \n",
    "                  'cM1':'cM0_or_cM1', \n",
    "                  'Staging Incomplete':'Staging_Incomplete'}\n",
    "\n",
    "annotations['Clin_Stage_Dist_Mets-cM'] = bf.binarizeCategorical(clinical, \n",
    "                                                                'Clin_Stage_Dist_Mets-cM', \n",
    "                                                                clin_stage_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "path_stage_map = {'Staging Incomplete': 'No_distant_metastasis', \n",
    "                  'No pathologic evidence of distant metastasis':'No_distant_metastasis', \n",
    "                  'pM1':'Distant_Metastasis'}\n",
    "\n",
    "annotations['Path_Stage_Dist_Mets-pM'] = bf.binarizeCategorical(clinical, \n",
    "                                                                'Path_Stage_Dist_Mets-pM', \n",
    "                                                                path_stage_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "tumor_stage_map = {'Stage I':'Stage_I_or_II', \n",
    "                   'Stage II':'Stage_I_or_II', \n",
    "                   'Stage III':'Stage_III_or_IV', \n",
    "                   'Stage IV':'Stage_III_or_IV'}\n",
    "\n",
    "annotations['tumor_Stage-Pathological'] = bf.binarizeCategorical(clinical, \n",
    "                                                               'tumor_Stage-Pathological', \n",
    "                                                               tumor_stage_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "FIGO_stage_map = {'IA':'I_or_II', \n",
    "                  'IB':'I_or_II', \n",
    "                  'II':'I_or_II', \n",
    "                  'IIIA':'III_or_IV', \n",
    "                  'IIIC1':'III_or_IV', \n",
    "                  'IVB':'III_or_IV', \n",
    "                  'IIIC2':'III_or_IV', \n",
    "                  'IIIB':'III_or_IV'}\n",
    "\n",
    "annotations['FIGO_stage'] = bf.binarizeCategorical(clinical, \n",
    "                                                   'FIGO_stage', \n",
    "                                                   FIGO_stage_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "diabetes_map = {'No':'No', \n",
    "                'Yes':'Yes', \n",
    "                'Unknown':'No'}\n",
    "\n",
    "annotations['Diabetes'] = bf.binarizeCategorical(clinical, \n",
    "                                                 'Diabetes', \n",
    "                                                 diabetes_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "race_map = {'White':'White', \n",
    "            'Black or African American':'Not_White', \n",
    "            'Asian':'Not_White', \n",
    "            'Not Reported':'Not_White'}\n",
    "\n",
    "annotations['Race'] = bf.binarizeCategorical(clinical, \n",
    "                                             'Race', \n",
    "                                             race_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "ethnicity_map = {'Not-Hispanic or Latino':'Not_Hispanic', \n",
    "                 'Not reported':'Not_Hispanic', \n",
    "                 'Hispanic or Latino':'Hispanic'}\n",
    "\n",
    "annotations['Ethnicity'] = bf.binarizeCategorical(clinical, \n",
    "                                                  'Ethnicity', \n",
    "                                                  ethnicity_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "tumor_site_map = {'Other, specify':'Not_Anterior', \n",
    "                  'Anterior endometrium':'Anterior', \n",
    "                  'Posterior endometrium':'Not_Anterior'}\n",
    "\n",
    "annotations['Tumor_Site'] = bf.binarizeCategorical(clinical, \n",
    "                                                   'Tumor_Site', \n",
    "                                                   tumor_site_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "annotations['Tumor_Size_cm'] = bf.binarizeCutOff(clinical, \n",
    "                                                'Tumor_Size_cm', 4.0, \n",
    "                                                'Large_tumor', \n",
    "                                                'Small_tumor')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "num_pregnancies_map = {2:'Less_than_3', \n",
    "                       1:'Less_than_3', \n",
    "                       'None':'Less_than_3', \n",
    "                       None:'Less_than_3', \n",
    "                       3:'3_or_more', \n",
    "                       '4 or more':'3_or_more'}\n",
    "\n",
    "annotations['Num_full_term_pregnancies'] = bf.binarizeCategorical(clinical, \n",
    "                                                                  'Num_full_term_pregnancies', \n",
    "                                                                  num_pregnancies_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "genomics_map = {'MSI-H':'MSI-H', \n",
    "                'CNV_low':'Other_subtype', \n",
    "                'CNV_high':'Other_subtype', \n",
    "                'POLE':'Other_subtype'}\n",
    "\n",
    "annotations['Genomics_subtype'] = bf.binarizeCategorical(clinical, \n",
    "                                                         'Genomics_subtype', \n",
    "                                                         genomics_map)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Step 3: Perform outliers analysis"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\Daniel\\AppData\\Local\\conda\\conda\\envs\\Research\\lib\\site-packages\\numpy\\lib\\nanfunctions.py:1391: RuntimeWarning: All-NaN slice encountered\n",
      "  overwrite_input, interpolation)\n"
     ]
    }
   ],
   "source": [
    "outliers_prot = blsh.make_outliers_table(proteomics, iqrs=1.5, \n",
    "                                         up_or_down='up', \n",
    "                                         aggregate=False, \n",
    "                                         frac_table=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "length = int(len(outliers_prot.index) / 2)\n",
    "only_outliers_up_prot = outliers_prot[:length]\n",
    "outlier_up_prot_dict = {}\n",
    "for i in range(length):\n",
    "    key = proteomics.index[i]\n",
    "    my_filter = only_outliers_up_prot.iloc[i] == 1.0\n",
    "    value = list(only_outliers_up_prot.iloc[i][my_filter].index)\n",
    "    outlier_up_prot_dict[key] = value"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Step 4: Wrap your A/B test into the outliers analysis, and create a table"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "results_prot = blsh.compare_groups_outliers(outliers_prot, \n",
    "                                            annotations)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Many of the output values from compare_group_outliers are NaN, so here we will get rid of the NaN values for visualization purposes."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "results_prot = results_prot.dropna(axis=0, how='all')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "sig_cols = []\n",
    "for col in results_prot.columns:\n",
    "    sig_col = bf.significantEnrichments(results_prot, col, 0.01)\n",
    "    if sig_col is not None and len(sig_col) > 5:\n",
    "        sig_cols.append(sig_col)\n",
    "    else:\n",
    "        results_prot = results_prot.drop(col, axis=1)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Step 5: Visualize these enrichments"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAfAAAAJcCAYAAAAGmvbuAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\ngQMAEIL+D+HJohid7Kf3AAAAAElFTkSuQmCC\n",
      "text/plain": [
       "<Figure size 576x396 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "axis = plt.axes()\n",
    "sns.heatmap(results_prot, ax = axis)\n",
    "axis.set_title(\"Significantly Up-Regulated Genes in Endometrial Cancer Tumors\")\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Step 6: Perform Gene Set Enrichment Analysis"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2019-08-22 13:20:56,824 Warning: No enrich terms using library KEGG_2019_Human when cutoff = 0.05\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "           Gene_set                                             Term Overlap  \\\n",
      "0   KEGG_2019_Human                                      Endocytosis   2/244   \n",
      "1   KEGG_2019_Human                    Glycosaminoglycan degradation    1/19   \n",
      "2   KEGG_2019_Human         Pentose and glucuronate interconversions    1/34   \n",
      "3   KEGG_2019_Human                                      Ferroptosis    1/40   \n",
      "4   KEGG_2019_Human             Porphyrin and chlorophyll metabolism    1/42   \n",
      "5   KEGG_2019_Human                               Mineral absorption    1/51   \n",
      "6   KEGG_2019_Human            Regulation of lipolysis in adipocytes    1/55   \n",
      "7   KEGG_2019_Human                  Fc epsilon RI signaling pathway    1/68   \n",
      "8   KEGG_2019_Human                  Adipocytokine signaling pathway    1/69   \n",
      "9   KEGG_2019_Human                           ErbB signaling pathway    1/85   \n",
      "10  KEGG_2019_Human                           GnRH signaling pathway    1/93   \n",
      "11  KEGG_2019_Human                T cell receptor signaling pathway   1/101   \n",
      "12  KEGG_2019_Human             Toll-like receptor signaling pathway   1/104   \n",
      "13  KEGG_2019_Human                                  Drug metabolism   1/108   \n",
      "14  KEGG_2019_Human                            TNF signaling pathway   1/110   \n",
      "15  KEGG_2019_Human                   Neurotrophin signaling pathway   1/119   \n",
      "16  KEGG_2019_Human                                         Lysosome   1/123   \n",
      "17  KEGG_2019_Human                       Osteoclast differentiation   1/127   \n",
      "18  KEGG_2019_Human                        Relaxin signaling pathway   1/130   \n",
      "19  KEGG_2019_Human           Fluid shear stress and atherosclerosis   1/139   \n",
      "20  KEGG_2019_Human                                      Necroptosis   1/162   \n",
      "21  KEGG_2019_Human                                      Hepatitis B   1/163   \n",
      "22  KEGG_2019_Human      Protein processing in endoplasmic reticulum   1/165   \n",
      "23  KEGG_2019_Human                                   Tight junction   1/170   \n",
      "24  KEGG_2019_Human                                      Influenza A   1/171   \n",
      "25  KEGG_2019_Human                                       Alcoholism   1/180   \n",
      "26  KEGG_2019_Human  Kaposi sarcoma-associated herpesvirus infection   1/186   \n",
      "27  KEGG_2019_Human                     Epstein-Barr virus infection   1/201   \n",
      "28  KEGG_2019_Human         Human immunodeficiency virus 1 infection   1/212   \n",
      "29  KEGG_2019_Human                           cAMP signaling pathway   1/212   \n",
      "30  KEGG_2019_Human                           MAPK signaling pathway   1/295   \n",
      "31  KEGG_2019_Human          Neuroactive ligand-receptor interaction   1/338   \n",
      "32  KEGG_2019_Human                 Herpes simplex virus 1 infection   1/492   \n",
      "\n",
      "     P-value  Adjusted P-value  Old P-value  Old Adjusted P-value  Odds Ratio  \\\n",
      "0   0.012246               1.0            0                     0   11.709602   \n",
      "1   0.013222               1.0            0                     0   75.187970   \n",
      "2   0.023546               1.0            0                     0   42.016807   \n",
      "3   0.027648               1.0            0                     0   35.714286   \n",
      "4   0.029011               1.0            0                     0   34.013605   \n",
      "5   0.035125               1.0            0                     0   28.011204   \n",
      "6   0.037831               1.0            0                     0   25.974026   \n",
      "7   0.046577               1.0            0                     0   21.008403   \n",
      "8   0.047246               1.0            0                     0   20.703934   \n",
      "9   0.057902               1.0            0                     0   16.806723   \n",
      "10  0.063188               1.0            0                     0   15.360983   \n",
      "11  0.068447               1.0            0                     0   14.144272   \n",
      "12  0.070412               1.0            0                     0   13.736264   \n",
      "13  0.073026               1.0            0                     0   13.227513   \n",
      "14  0.074330               1.0            0                     0   12.987013   \n",
      "15  0.080179               1.0            0                     0   12.004802   \n",
      "16  0.082767               1.0            0                     0   11.614402   \n",
      "17  0.085349               1.0            0                     0   11.248594   \n",
      "18  0.087280               1.0            0                     0   10.989011   \n",
      "19  0.093053               1.0            0                     0   10.277492   \n",
      "20  0.107652               1.0            0                     0    8.818342   \n",
      "21  0.108281               1.0            0                     0    8.764242   \n",
      "22  0.109540               1.0            0                     0    8.658009   \n",
      "23  0.112678               1.0            0                     0    8.403361   \n",
      "24  0.113304               1.0            0                     0    8.354219   \n",
      "25  0.118924               1.0            0                     0    7.936508   \n",
      "26  0.122652               1.0            0                     0    7.680492   \n",
      "27  0.131908               1.0            0                     0    7.107321   \n",
      "28  0.138638               1.0            0                     0    6.738544   \n",
      "29  0.138638               1.0            0                     0    6.738544   \n",
      "30  0.187879               1.0            0                     0    4.842615   \n",
      "31  0.212349               1.0            0                     0    4.226543   \n",
      "32  0.294481               1.0            0                     0    2.903600   \n",
      "\n",
      "    Combined Score      Genes  \n",
      "0        51.551753  EHD4;RBSN  \n",
      "1       325.251722       GUSB  \n",
      "2       157.512231       GUSB  \n",
      "3       128.150601       FTH1  \n",
      "4       120.410705       GUSB  \n",
      "5        93.804869       FTH1  \n",
      "6        85.055098        NPY  \n",
      "7        64.425482     MAP2K7  \n",
      "8        63.196222        NPY  \n",
      "9        47.882415     MAP2K7  \n",
      "10       42.421483     MAP2K7  \n",
      "11       37.930681     MAP2K7  \n",
      "12       36.447753     MAP2K7  \n",
      "13       34.615688       GUSB  \n",
      "14       33.756385     MAP2K7  \n",
      "15       30.294105     MAP2K7  \n",
      "16       28.939913       GUSB  \n",
      "17       27.682922     MAP2K7  \n",
      "18       26.798134     MAP2K7  \n",
      "19       24.404796     MAP2K7  \n",
      "20       19.654813       FTH1  \n",
      "21       19.483111     MAP2K7  \n",
      "22       19.146925     MAP2K7  \n",
      "23       18.346400     MAP2K7  \n",
      "24       18.192793     MAP2K7  \n",
      "25       16.898974        NPY  \n",
      "26       16.116776     MAP2K7  \n",
      "27       14.396947     MAP2K7  \n",
      "28       13.314614     MAP2K7  \n",
      "29       13.314614        NPY  \n",
      "30        8.096649     MAP2K7  \n",
      "31        6.549136        NPY  \n",
      "32        3.549774     ZNF605  \n",
      "            Gene_set                                         Term Overlap  \\\n",
      "0    KEGG_2019_Human            Ribosome biogenesis in eukaryotes  20/101   \n",
      "1    KEGG_2019_Human                                  Spliceosome  21/134   \n",
      "2    KEGG_2019_Human                    mRNA surveillance pathway   13/91   \n",
      "3    KEGG_2019_Human                                RNA transport  17/165   \n",
      "4    KEGG_2019_Human                     Hepatocellular carcinoma  14/168   \n",
      "5    KEGG_2019_Human                               RNA polymerase    5/31   \n",
      "6    KEGG_2019_Human               Ubiquitin mediated proteolysis   9/137   \n",
      "7    KEGG_2019_Human            Thyroid hormone signaling pathway   7/116   \n",
      "8    KEGG_2019_Human                              Mismatch repair    3/23   \n",
      "9    KEGG_2019_Human                            Pancreatic cancer    5/75   \n",
      "10   KEGG_2019_Human                               Thyroid cancer    3/37   \n",
      "11   KEGG_2019_Human                Cytosolic DNA-sensing pathway    4/63   \n",
      "12   KEGG_2019_Human                        Wnt signaling pathway   7/158   \n",
      "13   KEGG_2019_Human                 NF-kappa B signaling pathway    5/95   \n",
      "14   KEGG_2019_Human                               Bladder cancer    3/41   \n",
      "15   KEGG_2019_Human  Protein processing in endoplasmic reticulum   7/165   \n",
      "16   KEGG_2019_Human                            Adherens junction    4/72   \n",
      "17   KEGG_2019_Human                                  Influenza A   7/171   \n",
      "18   KEGG_2019_Human                                      Measles   6/138   \n",
      "19   KEGG_2019_Human         Other types of O-glycan biosynthesis    2/22   \n",
      "20   KEGG_2019_Human                                      Malaria    3/49   \n",
      "21   KEGG_2019_Human      Biosynthesis of unsaturated fatty acids    2/27   \n",
      "22   KEGG_2019_Human                           Lysine degradation    3/59   \n",
      "23   KEGG_2019_Human                                    Mitophagy    3/65   \n",
      "24   KEGG_2019_Human                   Non-small cell lung cancer    3/66   \n",
      "25   KEGG_2019_Human                 Longevity regulating pathway   4/102   \n",
      "26   KEGG_2019_Human  Alanine, aspartate and glutamate metabolism    2/35   \n",
      "27   KEGG_2019_Human                        p53 signaling pathway    3/72   \n",
      "28   KEGG_2019_Human     Glycine, serine and threonine metabolism    2/40   \n",
      "29   KEGG_2019_Human                                Thermogenesis   7/231   \n",
      "..               ...                                          ...     ...   \n",
      "129  KEGG_2019_Human                   Hematopoietic cell lineage    1/97   \n",
      "130  KEGG_2019_Human                         Pancreatic secretion    1/98   \n",
      "131  KEGG_2019_Human                 Choline metabolism in cancer    1/99   \n",
      "132  KEGG_2019_Human                      HIF-1 signaling pathway   1/100   \n",
      "133  KEGG_2019_Human            T cell receptor signaling pathway   1/101   \n",
      "134  KEGG_2019_Human                                Melanogenesis   1/101   \n",
      "135  KEGG_2019_Human                                Axon guidance   2/181   \n",
      "136  KEGG_2019_Human                    Th17 cell differentiation   1/107   \n",
      "137  KEGG_2019_Human                        TNF signaling pathway   1/110   \n",
      "138  KEGG_2019_Human                    Calcium signaling pathway   2/188   \n",
      "139  KEGG_2019_Human         Leukocyte transendothelial migration   1/112   \n",
      "140  KEGG_2019_Human                           Huntington disease   2/193   \n",
      "141  KEGG_2019_Human               Sphingolipid signaling pathway   1/119   \n",
      "142  KEGG_2019_Human                          Platelet activation   1/124   \n",
      "143  KEGG_2019_Human                            Purine metabolism   1/129   \n",
      "144  KEGG_2019_Human     Human immunodeficiency virus 1 infection   2/212   \n",
      "145  KEGG_2019_Human    Natural killer cell mediated cytotoxicity   1/131   \n",
      "146  KEGG_2019_Human                   PI3K-Akt signaling pathway   4/354   \n",
      "147  KEGG_2019_Human                       FoxO signaling pathway   1/132   \n",
      "148  KEGG_2019_Human             Herpes simplex virus 1 infection   6/492   \n",
      "149  KEGG_2019_Human                    Insulin signaling pathway   1/137   \n",
      "150  KEGG_2019_Human       Cytokine-cytokine receptor interaction   3/294   \n",
      "151  KEGG_2019_Human              Human cytomegalovirus infection   2/225   \n",
      "152  KEGG_2019_Human                        Ras signaling pathway   2/232   \n",
      "153  KEGG_2019_Human                       mTOR signaling pathway   1/152   \n",
      "154  KEGG_2019_Human                   Oxytocin signaling pathway   1/153   \n",
      "155  KEGG_2019_Human                   cGMP-PKG signaling pathway   1/166   \n",
      "156  KEGG_2019_Human                                 Tuberculosis   1/179   \n",
      "157  KEGG_2019_Human                       Rap1 signaling pathway   1/206   \n",
      "158  KEGG_2019_Human                                  Endocytosis   1/244   \n",
      "\n",
      "          P-value  Adjusted P-value  Old P-value  Old Adjusted P-value  \\\n",
      "0    1.734349e-14      5.341794e-12            0                     0   \n",
      "1    4.867850e-13      7.496489e-11            0                     0   \n",
      "2    4.457407e-08      4.576271e-06            0                     0   \n",
      "3    5.744773e-08      4.423475e-06            0                     0   \n",
      "4    1.049896e-05      6.467360e-04            0                     0   \n",
      "5    3.954894e-04      2.030179e-02            0                     0   \n",
      "6    2.160703e-03      9.507094e-02            0                     0   \n",
      "7    1.023745e-02      3.941419e-01            0                     0   \n",
      "8    1.131754e-02      3.873115e-01            0                     0   \n",
      "9    1.926734e-02      5.934341e-01            0                     0   \n",
      "10   4.023428e-02      1.000000e+00            0                     0   \n",
      "11   4.084921e-02      1.000000e+00            0                     0   \n",
      "12   4.553337e-02      1.000000e+00            0                     0   \n",
      "13   4.660759e-02      1.000000e+00            0                     0   \n",
      "14   5.201160e-02      1.000000e+00            0                     0   \n",
      "15   5.508553e-02      1.000000e+00            0                     0   \n",
      "16   6.126004e-02      1.000000e+00            0                     0   \n",
      "17   6.419780e-02      1.000000e+00            0                     0   \n",
      "18   6.621038e-02      1.000000e+00            0                     0   \n",
      "19   7.460095e-02      1.000000e+00            0                     0   \n",
      "20   7.987912e-02      1.000000e+00            0                     0   \n",
      "21   1.060989e-01      1.000000e+00            0                     0   \n",
      "22   1.218001e-01      1.000000e+00            0                     0   \n",
      "23   1.500627e-01      1.000000e+00            0                     0   \n",
      "24   1.549635e-01      1.000000e+00            0                     0   \n",
      "25   1.593514e-01      1.000000e+00            0                     0   \n",
      "26   1.620024e-01      1.000000e+00            0                     0   \n",
      "27   1.853426e-01      1.000000e+00            0                     0   \n",
      "28   1.991056e-01      1.000000e+00            0                     0   \n",
      "29   2.006142e-01      1.000000e+00            0                     0   \n",
      "..            ...               ...          ...                   ...   \n",
      "129  8.678703e-01      1.000000e+00            0                     0   \n",
      "130  8.706054e-01      1.000000e+00            0                     0   \n",
      "131  8.732840e-01      1.000000e+00            0                     0   \n",
      "132  8.759073e-01      1.000000e+00            0                     0   \n",
      "133  8.784764e-01      1.000000e+00            0                     0   \n",
      "134  8.784764e-01      1.000000e+00            0                     0   \n",
      "135  8.900098e-01      1.000000e+00            0                     0   \n",
      "136  8.928143e-01      1.000000e+00            0                     0   \n",
      "137  8.993372e-01      1.000000e+00            0                     0   \n",
      "138  9.021109e-01      1.000000e+00            0                     0   \n",
      "139  9.034643e-01      1.000000e+00            0                     0   \n",
      "140  9.099824e-01      1.000000e+00            0                     0   \n",
      "141  9.166242e-01      1.000000e+00            0                     0   \n",
      "142  9.249132e-01      1.000000e+00            0                     0   \n",
      "143  9.323799e-01      1.000000e+00            0                     0   \n",
      "144  9.348027e-01      1.000000e+00            0                     0   \n",
      "145  9.351548e-01      1.000000e+00            0                     0   \n",
      "146  9.358532e-01      1.000000e+00            0                     0   \n",
      "147  9.364994e-01      1.000000e+00            0                     0   \n",
      "148  9.419269e-01      1.000000e+00            0                     0   \n",
      "149  9.428164e-01      1.000000e+00            0                     0   \n",
      "150  9.435540e-01      1.000000e+00            0                     0   \n",
      "151  9.478909e-01      1.000000e+00            0                     0   \n",
      "152  9.538613e-01      1.000000e+00            0                     0   \n",
      "153  9.582472e-01      1.000000e+00            0                     0   \n",
      "154  9.591138e-01      1.000000e+00            0                     0   \n",
      "155  9.688747e-01      1.000000e+00            0                     0   \n",
      "156  9.763095e-01      1.000000e+00            0                     0   \n",
      "157  9.865680e-01      1.000000e+00            0                     0   \n",
      "158  9.939635e-01      1.000000e+00            0                     0   \n",
      "\n",
      "     Odds Ratio  Combined Score  \\\n",
      "0      9.612612      304.580979   \n",
      "1      7.607593      215.682521   \n",
      "2      6.934813      117.379428   \n",
      "3      5.001471       83.386477   \n",
      "4      4.045307       46.376352   \n",
      "5      7.829627       61.348157   \n",
      "6      3.189001       19.571927   \n",
      "7      2.929361       13.421459   \n",
      "8      6.331786       28.375271   \n",
      "9      3.236246       12.781048   \n",
      "10     3.935975       12.646428   \n",
      "11     3.082139        9.856273   \n",
      "12     2.150670        6.644085   \n",
      "13     2.554931        7.833398   \n",
      "14     3.551977       10.500670   \n",
      "15     2.059429        5.970014   \n",
      "16     2.696872        7.531358   \n",
      "17     1.987169        5.456340   \n",
      "18     2.110595        5.730093   \n",
      "19     4.413063       11.454554   \n",
      "20     2.972063        7.511118   \n",
      "21     3.595829        8.066823   \n",
      "22     2.468323        5.196743   \n",
      "23     2.240478        4.249519   \n",
      "24     2.206531        4.114223   \n",
      "25     1.903674        3.496371   \n",
      "26     2.773925        5.048943   \n",
      "27     2.022654        3.409283   \n",
      "28     2.427184        3.917281   \n",
      "29     1.471021        2.363006   \n",
      "..          ...             ...   \n",
      "129    0.500450        0.070920   \n",
      "130    0.495344        0.068638   \n",
      "131    0.490340        0.066438   \n",
      "132    0.485437        0.064318   \n",
      "133    0.480631        0.062273   \n",
      "134    0.480631        0.062273   \n",
      "135    0.536394        0.062502   \n",
      "136    0.453679        0.051437   \n",
      "137    0.441306        0.046821   \n",
      "138    0.516422        0.053201   \n",
      "139    0.433426        0.044001   \n",
      "140    0.503043        0.047452   \n",
      "141    0.407930        0.035513   \n",
      "142    0.391481        0.030557   \n",
      "143    0.376308        0.026347   \n",
      "144    0.457959        0.030876   \n",
      "145    0.370563        0.024844   \n",
      "146    0.548516        0.036365   \n",
      "147    0.367755        0.024127   \n",
      "148    0.591996        0.035418   \n",
      "149    0.354333        0.020864   \n",
      "150    0.495344        0.028780   \n",
      "151    0.431499        0.023092   \n",
      "152    0.418480        0.019768   \n",
      "153    0.319366        0.013621   \n",
      "154    0.317279        0.013245   \n",
      "155    0.292432        0.009247   \n",
      "156    0.271194        0.006502   \n",
      "157    0.235649        0.003187   \n",
      "158    0.198950        0.001205   \n",
      "\n",
      "                                                 Genes  \n",
      "0    NOP58;UTP6;CSNK2A1;UTP4;WDR3;RPP40;HEATR1;WDR7...  \n",
      "1    SF3B4;TCERG1;AQR;RBM25;SF3B2;EIF4A3;DDX23;PRPF...  \n",
      "2    UPF2;UPF1;SMG1;RNGTT;CPSF1;RNMT;CPSF3;EIF4A3;C...  \n",
      "3    UPF2;UPF1;GEMIN2;EIF4A3;RPP40;NUP153;CASC3;SEN...  \n",
      "4    SMARCE1;SMARCD1;SMARCC1;SMARCB1;PHF10;CDKN2A;A...  \n",
      "5                   POLR3A;POLR3B;POLR2B;POLR3C;POLR3E  \n",
      "6    UBE2C;UBE2S;FBXO2;UBR5;KEAP1;UBE2J2;SAE1;PRPF1...  \n",
      "7              MED12;MED1;MED14;MED24;STAT1;TP53;MED17  \n",
      "8                                       MSH6;RFC4;MSH2  \n",
      "9                       STAT1;CDKN2A;ERBB2;TP53;BCL2L1  \n",
      "10                                     PAX8;CCDC6;TP53  \n",
      "11                         POLR3A;POLR3B;POLR3C;POLR3E  \n",
      "12         SFRP2;CSNK2A1;TBL1XR1;CHD8;WNT7A;SENP2;TP53  \n",
      "13                     CD40;VCAM1;CSNK2A1;PARP1;BCL2L1  \n",
      "14                                   CDKN2A;ERBB2;TP53  \n",
      "15      GANAB;NPLOC4;FBXO2;EIF2AK2;UBE2J2;PDIA6;HSPBP1  \n",
      "16                         CSNK2A1;ERBB2;WASF1;NECTIN3  \n",
      "17          NXF1;XPO1;STAT1;STAT2;TNFSF10;EIF2AK2;RAE1  \n",
      "18             CSNK2A1;STAT1;STAT2;EIF2AK2;TP53;BCL2L1  \n",
      "19                                     POFUT1;COLGALT1  \n",
      "20                                    CD40;VCAM1;THBS2  \n",
      "21                                         ACOT7;FADS1  \n",
      "22                                EHMT2;KMT2B;COLGALT1  \n",
      "23                                 CSNK2A1;TP53;BCL2L1  \n",
      "24                                   CDKN2A;ERBB2;TP53  \n",
      "25                             EHMT2;RB1CC1;ATG13;TP53  \n",
      "26                                           CAD;NAT8L  \n",
      "27                                  CDKN2A;TP53;BCL2L1  \n",
      "28                                            GLDC;CBS  \n",
      "29   SMARCE1;SMARCD1;SMARCC1;SMARCB1;ACTL6A;ARID1A;...  \n",
      "..                                                 ...  \n",
      "129                                               CD38  \n",
      "130                                               CD38  \n",
      "131                                              WASF1  \n",
      "132                                              ERBB2  \n",
      "133                                               PAK2  \n",
      "134                                              WNT7A  \n",
      "135                                         L1CAM;PAK2  \n",
      "136                                              STAT1  \n",
      "137                                              VCAM1  \n",
      "138                                         ERBB2;CD38  \n",
      "139                                              VCAM1  \n",
      "140                                        POLR2B;TP53  \n",
      "141                                               TP53  \n",
      "142                                              PRKCI  \n",
      "143                                               GMPS  \n",
      "144                                        PAK2;BCL2L1  \n",
      "145                                            TNFSF10  \n",
      "146                            ERBB2;THBS2;TP53;BCL2L1  \n",
      "147                                            TNFSF10  \n",
      "148               NXF1;STAT1;STAT2;EIF2AK2;TP53;BCL2L1  \n",
      "149                                              PRKCI  \n",
      "150                                 CD40;TNFSF10;INHBA  \n",
      "151                                        CDKN2A;TP53  \n",
      "152                                        PAK2;BCL2L1  \n",
      "153                                              WNT7A  \n",
      "154                                               CD38  \n",
      "155                                           GTF2IRD1  \n",
      "156                                              STAT1  \n",
      "157                                              PRKCI  \n",
      "158                                              PRKCI  \n",
      "\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[159 rows x 10 columns]\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2019-08-22 13:21:06,235 Warning: No enrich terms using library KEGG_2019_Human when cutoff = 0.05\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "          Gene_set                                      Term Overlap  \\\n",
      "0  KEGG_2019_Human   Glyoxylate and dicarboxylate metabolism    1/30   \n",
      "1  KEGG_2019_Human  Glycine, serine and threonine metabolism    1/40   \n",
      "2  KEGG_2019_Human                             RNA transport   1/165   \n",
      "\n",
      "    P-value  Adjusted P-value  Old P-value  Old Adjusted P-value  Odds Ratio  \\\n",
      "0  0.011939               1.0            0                     0   83.333333   \n",
      "1  0.015891               1.0            0                     0   62.500000   \n",
      "2  0.064136               1.0            0                     0   15.151515   \n",
      "\n",
      "   Combined Score Genes  \n",
      "0      368.994341  GLDC  \n",
      "1      258.874854  GLDC  \n",
      "2       41.617414  XPO5  \n"
     ]
    }
   ],
   "source": [
    "for col in sig_cols:\n",
    "    col_name = col.columns[0]\n",
    "    gene_name_list = list(col.index)\n",
    "    enrichment = gp.enrichr(gene_list = gene_name_list, \n",
    "                            description=col_name, \n",
    "                            gene_sets='KEGG_2019_Human',\n",
    "                            outdir='test/endometrial')\n",
    "    print(enrichment.res2d)\n",
    "    barplot(enrichment.res2d, title=col_name)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Step 7: Connect findings with the Genome Druggable Interactive Database (DGIdb)\n",
    "\n",
    "Our goal is to find personalized medicines based on specific clinical attributes, for individual patients, and to see how their current medicines are helping, hurting, or are indifferent towards their cancer treatment."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Step 7a: Personalized Medicine by Clinical Attributes\n",
    "After performing our outlier analyses, we find that there are groups of patients that have a common set of significantly up or down regulated genes grouped by clinical attributes. Here we will use those groups to find drugs best suited to both bring those gene enrichments to normal levels, and aid in the treatment of their cancer\n",
    "\n",
    "First, we will perform HTTP GET requests to DGIdb for all of our significantly up-regulated genes by clinical attribute.  Note, that we will want to look for drugs with an interaction type of 'inhibitor' for up-regulated genes."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "#Here we will link clinical attributes with significantly up-regulated genes\n",
    "sig_genes_up = {}\n",
    "for i, col in enumerate(sig_cols):\n",
    "    list_of_genes = list(col.index)\n",
    "    sig_genes_up[sig_cols[i].columns[0][:-9]] = list_of_genes"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "This will perform a general HTTP GET request to DGIdb.  While this is fast, it would be worthwile to search specifically for drugs that are inhibitors to patients' significantly up-regulated genes, so we will compare both queries below."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "#General GET Request\n",
    "requests_up = list(map(bf.dgidb_get_request, sig_genes_up.values()))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "UP-REGULATED GENERAL REQUEST:\n",
      "\n",
      "{\n",
      "    \"Proteomics_Tumor_Normal_Other_tumor\": {\n",
      "        \"FTH1\": {\n",
      "            \"IRON DEXTRAN\": [\n",
      "                \"other\"\n",
      "            ]\n",
      "        },\n",
      "        \"GNLY\": {\n",
      "            \"MYELOPEROXIDASE\": []\n",
      "        },\n",
      "        \"MAP2K7\": {\n",
      "            \"COBIMETINIB\": [\n",
      "                \"allosteric modulator\",\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"Refametinib\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TRAMETINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AZD-8330\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"SELUMETINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PD-0325901\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DABRAFENIB MESYLATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"BINIMETINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"IODOACETAMIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"WX-554\": []\n",
      "        },\n",
      "        \"NPY\": {\n",
      "            \"HALOPERIDOL\": [],\n",
      "            \"ESTRADIOL BENZOATE\": [],\n",
      "            \"BROMOCRIPTINE\": [],\n",
      "            \"ETHER\": [],\n",
      "            \"ROSIGLITAZONE\": [],\n",
      "            \"K-252A\": [],\n",
      "            \"CHEMBL1230906\": []\n",
      "        }\n",
      "    },\n",
      "    \"Histologic_type_Serous\": {\n",
      "        \"ACTL6A\": {\n",
      "            \"CHEMBL225155\": [\n",
      "                \"agonist\"\n",
      "            ]\n",
      "        },\n",
      "        \"ARID1A\": {\n",
      "            \"TRASTUZUMAB\": [],\n",
      "            \"DASATINIB\": [],\n",
      "            \"CHEMBL3287735\": []\n",
      "        },\n",
      "        \"BCL2L1\": {\n",
      "            \"CHEMBL106708\": [],\n",
      "            \"NAVITOCLAX\": [\n",
      "                \"antagonist\",\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ISOSORBIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL376408\": [\n",
      "                \"antagonist\"\n",
      "            ],\n",
      "            \"VENETOCLAX\": [\n",
      "                \"antagonist\"\n",
      "            ],\n",
      "            \"OBATOCLAX MESYLATE\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"CAD\": {\n",
      "            \"ASPARTIC ACID\": [],\n",
      "            \"PALA\": []\n",
      "        },\n",
      "        \"CARM1\": {\n",
      "            \"CHEMBL468927\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PREGNENOLONE\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"CBS\": {\n",
      "            \"PYRIDOXAL PHOSPHATE\": [\n",
      "                \"cofactor\"\n",
      "            ],\n",
      "            \"S-ADENOSYL-L-METHIONINE\": [\n",
      "                \"activator\"\n",
      "            ],\n",
      "            \"SERINE\": [],\n",
      "            \"CYSTEINE\": [],\n",
      "            \"ARSENIC\": []\n",
      "        },\n",
      "        \"CD38\": {\n",
      "            \"DARATUMUMAB\": [\n",
      "                \"inhibitor\",\n",
      "                \"antibody\"\n",
      "            ],\n",
      "            \"ISATUXIMAB\": [\n",
      "                \"antibody\"\n",
      "            ],\n",
      "            \"THROMBIN\": [],\n",
      "            \"HuMax-CD38\": [],\n",
      "            \"SAR-650984\": []\n",
      "        },\n",
      "        \"CD40\": {\n",
      "            \"FLUDARABINE\": [],\n",
      "            \"HYDROQUINONE\": [],\n",
      "            \"STREPTOZOTOCIN\": [],\n",
      "            \"TETANUS TOXOID\": [],\n",
      "            \"DACETUZUMAB\": [\n",
      "                \"antibody\",\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PG-102\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LUCATUMUMAB\": [],\n",
      "            \"TENELIXIMAB\": [\n",
      "                \"partial agonist\"\n",
      "            ]\n",
      "        },\n",
      "        \"CDK11B\": {\n",
      "            \"AZD-5438\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PHA-793887\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"Roniciclib\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AT-7519\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"CDK12\": {\n",
      "            \"OLAPARIB\": [],\n",
      "            \"AZD-5438\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PHA-793887\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AT-7519\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"Roniciclib\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"CDKN2A\": {\n",
      "            \"PALBOCICLIB\": [],\n",
      "            \"LETROZOLE\": [],\n",
      "            \"Ribociclib\": [],\n",
      "            \"Roniciclib\": [],\n",
      "            \"ABEMACICLIB\": [],\n",
      "            \"ILORASERTIB\": [],\n",
      "            \"PANITUMUMAB\": [],\n",
      "            \"TRAMETINIB\": [],\n",
      "            \"GEMCITABINE\": [],\n",
      "            \"CHEMBL1231206\": [],\n",
      "            \"PF-00477736\": [],\n",
      "            \"GSK-461364\": [],\n",
      "            \"HMN-214\": [],\n",
      "            \"ALVOCIDIB\": [],\n",
      "            \"IMATINIB\": [],\n",
      "            \"CARBOPLATIN\": [],\n",
      "            \"PACLITAXEL\": [],\n",
      "            \"INK-128\": [],\n",
      "            \"ALECTINIB\": [],\n",
      "            \"CRIZOTINIB\": []\n",
      "        },\n",
      "        \"CIP2A\": {\n",
      "            \"GEMCITABINE\": []\n",
      "        },\n",
      "        \"CSNK2A1\": {\n",
      "            \"SILMITASERTIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL92361\": [],\n",
      "            \"CHEMBL270512\": [],\n",
      "            \"RESVERATROL\": [],\n",
      "            \"CHEMBL574060\": [],\n",
      "            \"BENZAMIDINE\": [],\n",
      "            \"CHEMBL572879\": [],\n",
      "            \"CHEMBL1230989\": [],\n",
      "            \"TETRABROMOBENZOTRIAZOLE\": [],\n",
      "            \"CHEMBL376505\": [],\n",
      "            \"CHEMBL222476\": [],\n",
      "            \"EMODIN\": [],\n",
      "            \"CHEMBL273101\": [],\n",
      "            \"CHEMBL404508\": [],\n",
      "            \"CHEMBL231095\": [],\n",
      "            \"CHEMBL389767\": [],\n",
      "            \"CHEMBL438303\": [],\n",
      "            \"CHEMBL230347\": [],\n",
      "            \"CHEMBL230137\": [],\n",
      "            \"CHEMBL230354\": [],\n",
      "            \"DICHLORORIBOBENZIMIDAZOLE\": [],\n",
      "            \"QUINALIZARIN\": [],\n",
      "            \"ELLAGIC ACID\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"HEPARIN\": []\n",
      "        },\n",
      "        \"DNMT3A\": {\n",
      "            \"AZACITIDINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DECITABINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DAUNORUBICIN\": [],\n",
      "            \"IDARUBICIN\": []\n",
      "        },\n",
      "        \"EHMT2\": {\n",
      "            \"CHEMBL569864\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL1231795\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL2441082\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"EIF2AK2\": {\n",
      "            \"CHEMBL1802728\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL235641\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"INTERFERON ALFA-2B\": []\n",
      "        },\n",
      "        \"ERBB2\": {\n",
      "            \"LAPATINIB\": [\n",
      "                \"antagonist\",\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PERTUZUMAB\": [\n",
      "                \"inhibitor\",\n",
      "                \"antibody\"\n",
      "            ],\n",
      "            \"TRASTUZUMAB\": [\n",
      "                \"inhibitor\",\n",
      "                \"antibody\"\n",
      "            ],\n",
      "            \"MARGETUXIMAB\": [\n",
      "                \"inhibitor\",\n",
      "                \"antibody\"\n",
      "            ],\n",
      "            \"ACALABRUTINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AEE-788\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AFATINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AC-480\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"BMS-690514\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CANERTINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CP-724714\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CUDC-101\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DACOMITINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"FALNIDAMOL\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"IBRUTINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MUBRITINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"NERATINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"Poziotinib\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"SAPITINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TESEVATINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"IGN-311\": [],\n",
      "            \"TRASTUZUMAB EMTANSINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"EVEROLIMUS\": [],\n",
      "            \"FULVESTRANT\": [],\n",
      "            \"PALBOCICLIB\": [],\n",
      "            \"TYRPHOSTIN AG 879\": [],\n",
      "            \"ANTHRAQUINONE\": [],\n",
      "            \"CHLORAMBUCIL\": [],\n",
      "            \"DEPSIPEPTIDE\": [],\n",
      "            \"DIETHYLSTILBESTROL\": [],\n",
      "            \"EMODIN\": [],\n",
      "            \"ETHYL NITROSOUREA\": [],\n",
      "            \"EPIRUBICIN\": [],\n",
      "            \"FILGRASTIM\": [],\n",
      "            \"FLOXURIDINE\": [],\n",
      "            \"ROMIDEPSIN\": [],\n",
      "            \"GEFITINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"GEMCITABINE\": [],\n",
      "            \"EPIGALOCATECHIN GALLATE\": [],\n",
      "            \"HYDROCORTISONE\": [],\n",
      "            \"PROXYPHYLLINE\": [],\n",
      "            \"ISOFLAVONE\": [],\n",
      "            \"MECHLORETHAMINE HYDROCHLORIDE\": [],\n",
      "            \"CHEMBL35482\": [],\n",
      "            \"VORINOSTAT\": [],\n",
      "            \"TAMOXIFEN\": [],\n",
      "            \"URACIL\": [],\n",
      "            \"VITAMIN E\": [],\n",
      "            \"CHEMBL2141478\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"SB-243213\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"INSM-18\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CIMAGLERMIN ALFA\": [],\n",
      "            \"Irbinitinib\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PELITINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"T-DM1\": [\n",
      "                \"antibody\"\n",
      "            ],\n",
      "            \"S-222611\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TAK-285\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LAPATINIB DITOSYLATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MOMELOTINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LITHOCHOLIC ACID\": [\n",
      "                \"antibody\"\n",
      "            ],\n",
      "            \"GANCICLOVIR\": [],\n",
      "            \"TIPIFARNIB\": [],\n",
      "            \"OSIMERTINIB\": [],\n",
      "            \"ROCILETINIB\": [],\n",
      "            \"MK-2206\": [],\n",
      "            \"ABEMACICLIB\": [],\n",
      "            \"LETROZOLE\": [],\n",
      "            \"ANASTROZOLE\": [],\n",
      "            \"EXEMESTANE\": [],\n",
      "            \"GONADORELIN\": [],\n",
      "            \"CRIZOTINIB\": [],\n",
      "            \"IRINOTECAN\": [],\n",
      "            \"DOCETAXEL\": [],\n",
      "            \"CAPECITABINE\": [],\n",
      "            \"PICTILISIB\": [],\n",
      "            \"CETUXIMAB\": [],\n",
      "            \"SIROLIMUS\": [],\n",
      "            \"PHENYLTHIOUREA\": [],\n",
      "            \"MM-302\": [],\n",
      "            \"PACLITAXEL\": [],\n",
      "            \"VARLITINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"VS-5584\": [],\n",
      "            \"PKI-179\": [],\n",
      "            \"ARQ-092\": [],\n",
      "            \"BUPARLISIB\": [],\n",
      "            \"BEVACIZUMAB\": [],\n",
      "            \"PONATINIB\": [],\n",
      "            \"SORAFENIB\": [],\n",
      "            \"Pyrotinib\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PA-799\": [],\n",
      "            \"TASELISIB\": [],\n",
      "            \"CUDC-907\": [],\n",
      "            \"IPATASERTIB\": [],\n",
      "            \"COPANLISIB\": [],\n",
      "            \"GEDATOLISIB\": [],\n",
      "            \"AZD-4547\": [],\n",
      "            \"FLUOROURACIL\": [],\n",
      "            \"LEUCOVORIN\": [],\n",
      "            \"OXALIPLATIN\": [],\n",
      "            \"AMG-337\": [],\n",
      "            \"BGB-283\": [],\n",
      "            \"TEMSIROLIMUS\": [],\n",
      "            \"DEPATUXIZUMAB MAFODOTIN\": [],\n",
      "            \"ERLOTINIB\": [],\n",
      "            \"PANITUMUMAB\": [],\n",
      "            \"SELUMETINIB\": [],\n",
      "            \"PILARALISIB (CHEMBL3218575)\": [],\n",
      "            \"CHEMBL1229592\": [],\n",
      "            \"CI-1040\": [],\n",
      "            \"CHEMBL392068\": [],\n",
      "            \"AT-13148\": [],\n",
      "            \"ENTINOSTAT\": [],\n",
      "            \"TRODUSQUEMINE\": [],\n",
      "            \"DOXORUBICIN\": [],\n",
      "            \"CYCLOPHOSPHAMIDE\": [],\n",
      "            \"SUNITINIB\": [],\n",
      "            \"METFORMIN\": [],\n",
      "            \"VINORELBINE BASE\": [],\n",
      "            \"TEGAFUR\": [],\n",
      "            \"LAPULEUCEL-T\": [],\n",
      "            \"RILOTUMUMAB\": [],\n",
      "            \"ONARTUZUMAB\": [],\n",
      "            \"OLAPARIB\": [],\n",
      "            \"SERIBANTUMAB\": [],\n",
      "            \"RAMUCIRUMAB\": [],\n",
      "            \"AZD-8055\": [],\n",
      "            \"BENZONATATE\": [],\n",
      "            \"TIVOZANIB\": [],\n",
      "            \"AFATINIB DIMALEATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"OSIMERTINIB MESYLATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"Allitinib\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"JNJ-26483327\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MP-412\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"Hemay-022\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CANERTINIB DIHYDROCHLORIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DACOMITINIB HYDRATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ERTUMAXOMAB\": [],\n",
      "            \"MDX-210\": [],\n",
      "            \"VANDETANIB\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"FADS1\": {\n",
      "            \"LINOLENIC ACID\": [\n",
      "                \"ligand\"\n",
      "            ],\n",
      "            \"ICOSAPENT\": [\n",
      "                \"agonist\"\n",
      "            ]\n",
      "        },\n",
      "        \"GANAB\": {\n",
      "            \"MIGLITOL\": [\n",
      "                \"antagonist\"\n",
      "            ]\n",
      "        },\n",
      "        \"GLDC\": {\n",
      "            \"PYRIDOXAL PHOSPHATE\": [\n",
      "                \"cofactor\"\n",
      "            ],\n",
      "            \"GLYCINE\": []\n",
      "        },\n",
      "        \"GMPS\": {\n",
      "            \"L-GLUTAMATE\": []\n",
      "        },\n",
      "        \"HCK\": {\n",
      "            \"BOSUTINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"IBRUTINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL1081312\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL306380\": [],\n",
      "            \"CHEMBL286939\": [],\n",
      "            \"QUERCETIN\": [],\n",
      "            \"DASATINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ENMD-981693\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ILORASERTIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"XL-228\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TG100-801\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MASITINIB\": [],\n",
      "            \"NINTEDANIB\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"ILF3\": {\n",
      "            \"CYCLOSPORINE\": []\n",
      "        },\n",
      "        \"INHBA\": {\n",
      "            \"SOTATERCEPT\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"KDM2A\": {\n",
      "            \"CHEMBL2164243\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"KEAP1\": {\n",
      "            \"DIMETHYL FUMARATE\": [\n",
      "                \"inhibitor\",\n",
      "                \"binder\"\n",
      "            ],\n",
      "            \"BARDOXOLONE METHYL\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"KIF11\": {\n",
      "            \"CK0106023\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MONASTROL\": [],\n",
      "            \"CHEMBL205786\": [],\n",
      "            \"CHEMBL228369\": [],\n",
      "            \"CHEMBL481931\": [],\n",
      "            \"(R)-MON-97\": [],\n",
      "            \"CHEMBL205437\": [],\n",
      "            \"CHEMBL204459\": [],\n",
      "            \"CHEMBL380955\": [],\n",
      "            \"FILANESIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ISPINESIB (CHEMBL228814)\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LITRONESIB\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"KIF1A\": {\n",
      "            \"PHOSPHOMETHYLPHOSPHONIC ACID ADENYLATE ESTER\": [],\n",
      "            \"CHEMBL1230989\": []\n",
      "        },\n",
      "        \"KIF2C\": {\n",
      "            \"CHEMBL1230989\": []\n",
      "        },\n",
      "        \"KLC3\": {\n",
      "            \"PHENYLTHIOUREA\": [],\n",
      "            \"FLUOROURACIL\": [],\n",
      "            \"IFOSFAMIDE\": [],\n",
      "            \"OXALIPLATIN\": []\n",
      "        },\n",
      "        \"MED1\": {\n",
      "            \"BECOCALCIDIOL\": []\n",
      "        },\n",
      "        \"MSH2\": {\n",
      "            \"PEMBROLIZUMAB\": [],\n",
      "            \"NIVOLUMAB\": [],\n",
      "            \"IPILIMUMAB\": [],\n",
      "            \"ATEZOLIZUMAB\": [],\n",
      "            \"DURVALUMAB\": []\n",
      "        },\n",
      "        \"MSH6\": {\n",
      "            \"TEMOZOLOMIDE\": [],\n",
      "            \"PEMBROLIZUMAB\": [],\n",
      "            \"NIVOLUMAB\": [],\n",
      "            \"IPILIMUMAB\": [],\n",
      "            \"ATEZOLIZUMAB\": [],\n",
      "            \"DURVALUMAB\": []\n",
      "        },\n",
      "        \"MTHFD2\": {\n",
      "            \"TETRAHYDROFOLATE\": [\n",
      "                \"cofactor\"\n",
      "            ],\n",
      "            \"CHEMBL1161866\": []\n",
      "        },\n",
      "        \"MYO9B\": {\n",
      "            \"MANNOMUSTINE\": [],\n",
      "            \"CAFFEINE\": [],\n",
      "            \"CAPTOPRIL\": [],\n",
      "            \"DIBUCAINE\": [],\n",
      "            \"FELODIPINE\": [],\n",
      "            \"PROPYLTHIOURACIL\": [],\n",
      "            \"VOLANESORSEN SODIUM\": [],\n",
      "            \"STREPTOZOTOCIN\": [],\n",
      "            \"TESTOSTERONE\": [],\n",
      "            \"WORTMANNIN\": [],\n",
      "            \"NIFEDIPINE\": []\n",
      "        },\n",
      "        \"PAK2\": {\n",
      "            \"SELEGILINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"STAUROSPORINE\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"PARP1\": {\n",
      "            \"CHEMBL123904\": [],\n",
      "            \"NIACINAMIDE\": [\n",
      "                \"binder\"\n",
      "            ],\n",
      "            \"CHEMBL401843\": [],\n",
      "            \"CHEMBL123978\": [],\n",
      "            \"CHEMBL125200\": [],\n",
      "            \"CHEMBL134022\": [],\n",
      "            \"CHEMBL338790\": [],\n",
      "            \"VELIPARIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL452800\": [],\n",
      "            \"CHEMBL361054\": [],\n",
      "            \"OLAPARIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"RUCAPARIB\": [\n",
      "                \"inhibitor\",\n",
      "                \"antagonist\"\n",
      "            ],\n",
      "            \"NIRAPARIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"HEPTANOATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TALAZOPARIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"INOSINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"INIPARIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TALAZOPARIB TOSYLATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"RUCAPARIB CAMSYLATE\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"PDF\": {\n",
      "            \"CHEMBL431210\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"PRKCI\": {\n",
      "            \"CEP-2563\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"GF-109203\": [],\n",
      "            \"STAUROSPORINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"GSK-690693\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"(7S)-HYDROXYL-STAUROSPORINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"QUERCETIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MIDOSTAURIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"INGENOL MEBUTATE\": [],\n",
      "            \"SOTRASTAURIN\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"PRRC2A\": {\n",
      "            \"CARBAMAZEPINE\": []\n",
      "        },\n",
      "        \"SMARCA4\": {\n",
      "            \"TRETINOIN\": [],\n",
      "            \"VINORELBINE BASE\": []\n",
      "        },\n",
      "        \"SMARCA5\": {\n",
      "            \"DEXTROSE\": []\n",
      "        },\n",
      "        \"SMARCB1\": {\n",
      "            \"PANOBINOSTAT\": [],\n",
      "            \"PALBOCICLIB\": [],\n",
      "            \"ALVOCIDIB\": [],\n",
      "            \"FENRETINIDE\": [],\n",
      "            \"VORINOSTAT\": [],\n",
      "            \"PENTANAL\": []\n",
      "        },\n",
      "        \"STAT2\": {\n",
      "            \"ISOTRETINOIN\": []\n",
      "        },\n",
      "        \"THBS2\": {\n",
      "            \"CORTICOTROPIN\": [],\n",
      "            \"BEVACIZUMAB\": []\n",
      "        },\n",
      "        \"TK1\": {\n",
      "            \"THYMIDINE_TRIPHOSPHATE\": []\n",
      "        },\n",
      "        \"TNFSF10\": {\n",
      "            \"SODIUM BUTYRATE\": [],\n",
      "            \"TRICHOSTATIN\": []\n",
      "        },\n",
      "        \"TOP1\": {\n",
      "            \"CAMPTOTHECIN\": [],\n",
      "            \"EDOTECARIN\": [],\n",
      "            \"LUCANTHONE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ELSAMITRUCIN\": [],\n",
      "            \"7-ETHYL-10-HYDROXY-CAMPTOTHECIN\": [],\n",
      "            \"SODIUM STIBOGLUCONATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"KARENITECIN\": [],\n",
      "            \"CHEMBL343336\": [],\n",
      "            \"CAFFEINE\": [],\n",
      "            \"CYCLOPHOSPHAMIDE\": [],\n",
      "            \"BECATECARIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ETIRINOTECAN PEGOL\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"IRINOTECAN SUCROSOFATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LURTOTECAN\": [],\n",
      "            \"IRINOTECAN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TOPOTECAN\": [],\n",
      "            \"C-1311 (CHEMBL3545337)\": [],\n",
      "            \"RUBITECAN\": [],\n",
      "            \"IRINOTECAN HYDROCHLORIDE HYDRATE\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"TOP2A\": {\n",
      "            \"TENIPOSIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AMSACRINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"VALRUBICIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"EPIRUBICIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ENOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PEFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TROVAFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LOMEFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"NORFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LEVOFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"OFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PODOFILOX\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MITOXANTRONE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"SPARFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DOXORUBICIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ETOPOSIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"GENISTEIN\": [],\n",
      "            \"FLEROXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LUCANTHONE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"BANOXANTRONE\": [],\n",
      "            \"AMONAFIDE\": [],\n",
      "            \"ELSAMITRUCIN\": [],\n",
      "            \"BERUBICIN HYDROCHLORIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AMRUBICIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"FINAFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DAUNORUBICIN\": [],\n",
      "            \"DEXRAZOXANE\": [],\n",
      "            \"HYDROQUINONE\": [],\n",
      "            \"VINCRISTINE\": [],\n",
      "            \"VOSAROXIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AMRUBICIN HYDROCHLORIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ALDOXORUBICIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"BECATECARIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MM-302\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ETOPOSIDE PHOSPHATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DAUNORUBICIN CITRATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DAUNORUBICIN HYDROCHLORIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DOXORUBICIN HYDROCHLORIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MITOXANTRONE DIHYDROCHLORIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"IDARUBICIN\": [],\n",
      "            \"PACLITAXEL\": [],\n",
      "            \"C-1311 (CHEMBL3545337)\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DACTINOMYCIN\": [],\n",
      "            \"CAMPTOTHECIN\": [],\n",
      "            \"IDARUBICIN HYDROCHLORIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"IDRONOXIL\": []\n",
      "        },\n",
      "        \"TP53\": {\n",
      "            \"TARENFLURBIL\": [],\n",
      "            \"ASPIRIN\": [\n",
      "                \"acetylation\"\n",
      "            ],\n",
      "            \"Lesogaberan\": [],\n",
      "            \"CHEMBL1235116\": [],\n",
      "            \"DIETHYLSTILBESTROL\": [],\n",
      "            \"ENALAPRIL\": [],\n",
      "            \"RIZATRIPTAN\": [],\n",
      "            \"HALOPERIDOL\": [],\n",
      "            \"PROXYPHYLLINE\": [],\n",
      "            \"INOSITOL\": [],\n",
      "            \"INTERFERON ALFA-2B\": [],\n",
      "            \"CHEMBL1221512\": [],\n",
      "            \"METHIMAZOLE\": [],\n",
      "            \"METHYLPREDNISOLONE\": [],\n",
      "            \"MYCOPHENOLIC ACID\": [],\n",
      "            \"PACLITAXEL\": [],\n",
      "            \"PROPYLTHIOURACIL\": [],\n",
      "            \"PUROMYCIN\": [],\n",
      "            \"SIROLIMUS\": [],\n",
      "            \"RITUXIMAB\": [],\n",
      "            \"STREPTONIGRIN\": [],\n",
      "            \"TIRAPAZAMINE\": [],\n",
      "            \"THIOTEPA\": [],\n",
      "            \"TRIFLUOPERAZINE\": [],\n",
      "            \"URSODIOL\": [],\n",
      "            \"BEVACIZUMAB\": [],\n",
      "            \"VESNARINONE\": [],\n",
      "            \"YONDELIS\": [],\n",
      "            \"FLUOROURACIL\": [],\n",
      "            \"GARLIC\": [],\n",
      "            \"GOSSYPOL\": [],\n",
      "            \"GRANISETRON\": [],\n",
      "            \"ZINC CHLORIDE\": [],\n",
      "            \"BORTEZOMIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ABEMACICLIB\": [],\n",
      "            \"AZD-6738\": [],\n",
      "            \"DECITABINE\": [],\n",
      "            \"DOXORUBICIN\": [],\n",
      "            \"GEMCITABINE\": [],\n",
      "            \"MITOMYCIN\": [],\n",
      "            \"AZD-1775\": [],\n",
      "            \"PRAMLINTIDE\": [],\n",
      "            \"DOCETAXEL\": [],\n",
      "            \"SELUMETINIB\": [],\n",
      "            \"TAMOXIFEN\": [],\n",
      "            \"OXALIPLATIN\": [],\n",
      "            \"CETUXIMAB\": [],\n",
      "            \"CAPECITABINE\": [],\n",
      "            \"CARBOPLATIN\": [],\n",
      "            \"GANETESPIB\": [],\n",
      "            \"SELICICLIB\": [],\n",
      "            \"Tepotinib\": [],\n",
      "            \"CRIZOTINIB\": [],\n",
      "            \"CYCLOPHOSPHAMIDE\": [],\n",
      "            \"TOPOTECAN\": [],\n",
      "            \"DASATINIB\": [],\n",
      "            \"DEMCIZUMAB\": [],\n",
      "            \"INK-128\": [],\n",
      "            \"PD-0325901\": [],\n",
      "            \"VX-970\": [],\n",
      "            \"EPIRUBICIN\": [],\n",
      "            \"GEDATOLISIB\": [],\n",
      "            \"ENCORAFENIB\": [],\n",
      "            \"NAVITOCLAX\": [],\n",
      "            \"DABRAFENIB\": [],\n",
      "            \"PF-04217903\": [],\n",
      "            \"DACTOLISIB\": [],\n",
      "            \"IRINOTECAN\": [],\n",
      "            \"CHEMBL376408\": [],\n",
      "            \"ALPELISIB\": [],\n",
      "            \"TRAMETINIB\": [],\n",
      "            \"CYTARABINE\": [],\n",
      "            \"NUTLIN-3\": [],\n",
      "            \"PAZOPANIB\": [],\n",
      "            \"VORINOSTAT\": [],\n",
      "            \"HEMICHOLINIUM-3\": [],\n",
      "            \"PF-00477736\": [],\n",
      "            \"PRODIGIOSIN\": [],\n",
      "            \"TRIFLURIDINE\": [],\n",
      "            \"RG-547\": [],\n",
      "            \"LY-3009120\": [],\n",
      "            \"VEMURAFENIB\": [],\n",
      "            \"DAUNORUBICIN\": [],\n",
      "            \"IFOSFAMIDE\": [],\n",
      "            \"DS-7423\": [],\n",
      "            \"LORLATINIB\": [],\n",
      "            \"SP-600125\": [],\n",
      "            \"PHA-680632\": [],\n",
      "            \"OLAPARIB\": [],\n",
      "            \"AZD-5363\": [],\n",
      "            \"CAPMATINIB\": [],\n",
      "            \"AMG-337\": [],\n",
      "            \"TANESPIMYCIN\": [],\n",
      "            \"PANITUMUMAB\": [],\n",
      "            \"AMG-900\": [],\n",
      "            \"AZD-6482\": [],\n",
      "            \"IBRUTINIB\": [],\n",
      "            \"ALVESPIMYCIN\": [],\n",
      "            \"PIMASERTIB\": [],\n",
      "            \"CHEMBL303958\": [],\n",
      "            \"TEMOZOLOMIDE\": [],\n",
      "            \"RG-7602\": [],\n",
      "            \"ETOPOSIDE\": [],\n",
      "            \"PEMBROLIZUMAB\": [],\n",
      "            \"DUVELISIB\": [],\n",
      "            \"AZD-7762\": [],\n",
      "            \"ERLOTINIB\": [],\n",
      "            \"CHEMBL392068\": []\n",
      "        },\n",
      "        \"TPX2\": {\n",
      "            \"N (g)-NITRO-L-ARGININE\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"TUBB4A\": {\n",
      "            \"EPOTHILONE D\": [],\n",
      "            \"PATUPILONE\": [],\n",
      "            \"LEXIBULIN\": []\n",
      "        },\n",
      "        \"VCAM1\": {\n",
      "            \"CARVEDILOL\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"SUCCINOBUCOL\": [],\n",
      "            \"DEXAMETHASONE\": [],\n",
      "            \"PHORBOL MYRISTATE ACETATE\": [],\n",
      "            \"TROGLITAZONE\": [],\n",
      "            \"MERCAPTOPURINE\": [],\n",
      "            \"CYCLOSPORINE\": []\n",
      "        },\n",
      "        \"WNT7A\": {\n",
      "            \"DIETHYLSTILBESTROL\": []\n",
      "        },\n",
      "        \"XPO1\": {\n",
      "            \"SELINEXOR\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        }\n",
      "    },\n",
      "    \"LVSI_1.0\": {\n",
      "        \"GLDC\": {\n",
      "            \"PYRIDOXAL PHOSPHATE\": [\n",
      "                \"cofactor\"\n",
      "            ],\n",
      "            \"GLYCINE\": []\n",
      "        },\n",
      "        \"HAPLN1\": {\n",
      "            \"HYALURONIC ACID\": [\n",
      "                \"binder\"\n",
      "            ]\n",
      "        },\n",
      "        \"PRRC2A\": {\n",
      "            \"CARBAMAZEPINE\": []\n",
      "        }\n",
      "    }\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "} \n",
      "\n"
     ]
    }
   ],
   "source": [
    "print('UP-REGULATED GENERAL REQUEST:\\n')\n",
    "drug_dict_up = {}\n",
    "for i, request in enumerate(requests_up):\n",
    "    clinical_attribute = sig_cols[i].columns[0][:-9]\n",
    "    drug_dict_up[clinical_attribute] = bf.dgidb_json_parse(request, genes=True)\n",
    "print(json.dumps(drug_dict_up, indent=4), '\\n')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "inhibitors = []\n",
    "for genes in sig_genes_up.values():\n",
    "    inhibitors.append(bf.dgidb_get_request(genes, interaction_types=['inhibitor']))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "UP-REGULATED INHIBITORS:\n",
      "\n",
      "{\n",
      "    \"Proteomics_Tumor_Normal_Other_tumor\": {\n",
      "        \"FTH1\": {\n",
      "            \"IRON DEXTRAN\": [\n",
      "                \"other\"\n",
      "            ]\n",
      "        },\n",
      "        \"GNLY\": {\n",
      "            \"MYELOPEROXIDASE\": []\n",
      "        },\n",
      "        \"MAP2K7\": {\n",
      "            \"COBIMETINIB\": [\n",
      "                \"allosteric modulator\",\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"Refametinib\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TRAMETINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AZD-8330\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"SELUMETINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PD-0325901\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DABRAFENIB MESYLATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"BINIMETINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"IODOACETAMIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"WX-554\": []\n",
      "        },\n",
      "        \"NPY\": {\n",
      "            \"HALOPERIDOL\": [],\n",
      "            \"ESTRADIOL BENZOATE\": [],\n",
      "            \"BROMOCRIPTINE\": [],\n",
      "            \"ETHER\": [],\n",
      "            \"ROSIGLITAZONE\": [],\n",
      "            \"K-252A\": [],\n",
      "            \"CHEMBL1230906\": []\n",
      "        }\n",
      "    },\n",
      "    \"Histologic_type_Serous\": {\n",
      "        \"ACTL6A\": {\n",
      "            \"CHEMBL225155\": [\n",
      "                \"agonist\"\n",
      "            ]\n",
      "        },\n",
      "        \"ARID1A\": {\n",
      "            \"TRASTUZUMAB\": [],\n",
      "            \"DASATINIB\": [],\n",
      "            \"CHEMBL3287735\": []\n",
      "        },\n",
      "        \"BCL2L1\": {\n",
      "            \"CHEMBL106708\": [],\n",
      "            \"NAVITOCLAX\": [\n",
      "                \"antagonist\",\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ISOSORBIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL376408\": [\n",
      "                \"antagonist\"\n",
      "            ],\n",
      "            \"VENETOCLAX\": [\n",
      "                \"antagonist\"\n",
      "            ],\n",
      "            \"OBATOCLAX MESYLATE\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"CAD\": {\n",
      "            \"ASPARTIC ACID\": [],\n",
      "            \"PALA\": []\n",
      "        },\n",
      "        \"CARM1\": {\n",
      "            \"CHEMBL468927\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PREGNENOLONE\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"CBS\": {\n",
      "            \"PYRIDOXAL PHOSPHATE\": [\n",
      "                \"cofactor\"\n",
      "            ],\n",
      "            \"S-ADENOSYL-L-METHIONINE\": [\n",
      "                \"activator\"\n",
      "            ],\n",
      "            \"SERINE\": [],\n",
      "            \"CYSTEINE\": [],\n",
      "            \"ARSENIC\": []\n",
      "        },\n",
      "        \"CD38\": {\n",
      "            \"DARATUMUMAB\": [\n",
      "                \"inhibitor\",\n",
      "                \"antibody\"\n",
      "            ],\n",
      "            \"ISATUXIMAB\": [\n",
      "                \"antibody\"\n",
      "            ],\n",
      "            \"THROMBIN\": [],\n",
      "            \"HuMax-CD38\": [],\n",
      "            \"SAR-650984\": []\n",
      "        },\n",
      "        \"CD40\": {\n",
      "            \"FLUDARABINE\": [],\n",
      "            \"HYDROQUINONE\": [],\n",
      "            \"STREPTOZOTOCIN\": [],\n",
      "            \"TETANUS TOXOID\": [],\n",
      "            \"DACETUZUMAB\": [\n",
      "                \"antibody\",\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PG-102\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LUCATUMUMAB\": [],\n",
      "            \"TENELIXIMAB\": [\n",
      "                \"partial agonist\"\n",
      "            ]\n",
      "        },\n",
      "        \"CDK11B\": {\n",
      "            \"AZD-5438\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PHA-793887\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"Roniciclib\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AT-7519\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"CDK12\": {\n",
      "            \"OLAPARIB\": [],\n",
      "            \"AZD-5438\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PHA-793887\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AT-7519\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"Roniciclib\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"CDKN2A\": {\n",
      "            \"PALBOCICLIB\": [],\n",
      "            \"LETROZOLE\": [],\n",
      "            \"Ribociclib\": [],\n",
      "            \"Roniciclib\": [],\n",
      "            \"ABEMACICLIB\": [],\n",
      "            \"ILORASERTIB\": [],\n",
      "            \"PANITUMUMAB\": [],\n",
      "            \"TRAMETINIB\": [],\n",
      "            \"GEMCITABINE\": [],\n",
      "            \"CHEMBL1231206\": [],\n",
      "            \"PF-00477736\": [],\n",
      "            \"GSK-461364\": [],\n",
      "            \"HMN-214\": [],\n",
      "            \"ALVOCIDIB\": [],\n",
      "            \"IMATINIB\": [],\n",
      "            \"CARBOPLATIN\": [],\n",
      "            \"PACLITAXEL\": [],\n",
      "            \"INK-128\": [],\n",
      "            \"ALECTINIB\": [],\n",
      "            \"CRIZOTINIB\": []\n",
      "        },\n",
      "        \"CIP2A\": {\n",
      "            \"GEMCITABINE\": []\n",
      "        },\n",
      "        \"CSNK2A1\": {\n",
      "            \"SILMITASERTIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL92361\": [],\n",
      "            \"CHEMBL270512\": [],\n",
      "            \"RESVERATROL\": [],\n",
      "            \"CHEMBL574060\": [],\n",
      "            \"BENZAMIDINE\": [],\n",
      "            \"CHEMBL572879\": [],\n",
      "            \"CHEMBL1230989\": [],\n",
      "            \"TETRABROMOBENZOTRIAZOLE\": [],\n",
      "            \"CHEMBL376505\": [],\n",
      "            \"CHEMBL222476\": [],\n",
      "            \"EMODIN\": [],\n",
      "            \"CHEMBL273101\": [],\n",
      "            \"CHEMBL404508\": [],\n",
      "            \"CHEMBL231095\": [],\n",
      "            \"CHEMBL389767\": [],\n",
      "            \"CHEMBL438303\": [],\n",
      "            \"CHEMBL230347\": [],\n",
      "            \"CHEMBL230137\": [],\n",
      "            \"CHEMBL230354\": [],\n",
      "            \"DICHLORORIBOBENZIMIDAZOLE\": [],\n",
      "            \"QUINALIZARIN\": [],\n",
      "            \"ELLAGIC ACID\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"HEPARIN\": []\n",
      "        },\n",
      "        \"DNMT3A\": {\n",
      "            \"AZACITIDINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DECITABINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DAUNORUBICIN\": [],\n",
      "            \"IDARUBICIN\": []\n",
      "        },\n",
      "        \"EHMT2\": {\n",
      "            \"CHEMBL569864\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL1231795\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL2441082\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"EIF2AK2\": {\n",
      "            \"CHEMBL1802728\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL235641\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"INTERFERON ALFA-2B\": []\n",
      "        },\n",
      "        \"ERBB2\": {\n",
      "            \"LAPATINIB\": [\n",
      "                \"antagonist\",\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PERTUZUMAB\": [\n",
      "                \"inhibitor\",\n",
      "                \"antibody\"\n",
      "            ],\n",
      "            \"TRASTUZUMAB\": [\n",
      "                \"inhibitor\",\n",
      "                \"antibody\"\n",
      "            ],\n",
      "            \"MARGETUXIMAB\": [\n",
      "                \"inhibitor\",\n",
      "                \"antibody\"\n",
      "            ],\n",
      "            \"ACALABRUTINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AEE-788\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AFATINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AC-480\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"BMS-690514\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CANERTINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CP-724714\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CUDC-101\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DACOMITINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"FALNIDAMOL\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"IBRUTINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MUBRITINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"NERATINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"Poziotinib\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"SAPITINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TESEVATINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"IGN-311\": [],\n",
      "            \"TRASTUZUMAB EMTANSINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"EVEROLIMUS\": [],\n",
      "            \"FULVESTRANT\": [],\n",
      "            \"PALBOCICLIB\": [],\n",
      "            \"TYRPHOSTIN AG 879\": [],\n",
      "            \"ANTHRAQUINONE\": [],\n",
      "            \"CHLORAMBUCIL\": [],\n",
      "            \"DEPSIPEPTIDE\": [],\n",
      "            \"DIETHYLSTILBESTROL\": [],\n",
      "            \"EMODIN\": [],\n",
      "            \"ETHYL NITROSOUREA\": [],\n",
      "            \"EPIRUBICIN\": [],\n",
      "            \"FILGRASTIM\": [],\n",
      "            \"FLOXURIDINE\": [],\n",
      "            \"ROMIDEPSIN\": [],\n",
      "            \"GEFITINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"GEMCITABINE\": [],\n",
      "            \"EPIGALOCATECHIN GALLATE\": [],\n",
      "            \"HYDROCORTISONE\": [],\n",
      "            \"PROXYPHYLLINE\": [],\n",
      "            \"ISOFLAVONE\": [],\n",
      "            \"MECHLORETHAMINE HYDROCHLORIDE\": [],\n",
      "            \"CHEMBL35482\": [],\n",
      "            \"VORINOSTAT\": [],\n",
      "            \"TAMOXIFEN\": [],\n",
      "            \"URACIL\": [],\n",
      "            \"VITAMIN E\": [],\n",
      "            \"CHEMBL2141478\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"SB-243213\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"INSM-18\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CIMAGLERMIN ALFA\": [],\n",
      "            \"Irbinitinib\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PELITINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"T-DM1\": [\n",
      "                \"antibody\"\n",
      "            ],\n",
      "            \"S-222611\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TAK-285\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LAPATINIB DITOSYLATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MOMELOTINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LITHOCHOLIC ACID\": [\n",
      "                \"antibody\"\n",
      "            ],\n",
      "            \"GANCICLOVIR\": [],\n",
      "            \"TIPIFARNIB\": [],\n",
      "            \"OSIMERTINIB\": [],\n",
      "            \"ROCILETINIB\": [],\n",
      "            \"MK-2206\": [],\n",
      "            \"ABEMACICLIB\": [],\n",
      "            \"LETROZOLE\": [],\n",
      "            \"ANASTROZOLE\": [],\n",
      "            \"EXEMESTANE\": [],\n",
      "            \"GONADORELIN\": [],\n",
      "            \"CRIZOTINIB\": [],\n",
      "            \"IRINOTECAN\": [],\n",
      "            \"DOCETAXEL\": [],\n",
      "            \"CAPECITABINE\": [],\n",
      "            \"PICTILISIB\": [],\n",
      "            \"CETUXIMAB\": [],\n",
      "            \"SIROLIMUS\": [],\n",
      "            \"PHENYLTHIOUREA\": [],\n",
      "            \"MM-302\": [],\n",
      "            \"PACLITAXEL\": [],\n",
      "            \"VARLITINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"VS-5584\": [],\n",
      "            \"PKI-179\": [],\n",
      "            \"ARQ-092\": [],\n",
      "            \"BUPARLISIB\": [],\n",
      "            \"BEVACIZUMAB\": [],\n",
      "            \"PONATINIB\": [],\n",
      "            \"SORAFENIB\": [],\n",
      "            \"Pyrotinib\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PA-799\": [],\n",
      "            \"TASELISIB\": [],\n",
      "            \"CUDC-907\": [],\n",
      "            \"IPATASERTIB\": [],\n",
      "            \"COPANLISIB\": [],\n",
      "            \"GEDATOLISIB\": [],\n",
      "            \"AZD-4547\": [],\n",
      "            \"FLUOROURACIL\": [],\n",
      "            \"LEUCOVORIN\": [],\n",
      "            \"OXALIPLATIN\": [],\n",
      "            \"AMG-337\": [],\n",
      "            \"BGB-283\": [],\n",
      "            \"TEMSIROLIMUS\": [],\n",
      "            \"DEPATUXIZUMAB MAFODOTIN\": [],\n",
      "            \"ERLOTINIB\": [],\n",
      "            \"PANITUMUMAB\": [],\n",
      "            \"SELUMETINIB\": [],\n",
      "            \"PILARALISIB (CHEMBL3218575)\": [],\n",
      "            \"CHEMBL1229592\": [],\n",
      "            \"CI-1040\": [],\n",
      "            \"CHEMBL392068\": [],\n",
      "            \"AT-13148\": [],\n",
      "            \"ENTINOSTAT\": [],\n",
      "            \"TRODUSQUEMINE\": [],\n",
      "            \"DOXORUBICIN\": [],\n",
      "            \"CYCLOPHOSPHAMIDE\": [],\n",
      "            \"SUNITINIB\": [],\n",
      "            \"METFORMIN\": [],\n",
      "            \"VINORELBINE BASE\": [],\n",
      "            \"TEGAFUR\": [],\n",
      "            \"LAPULEUCEL-T\": [],\n",
      "            \"RILOTUMUMAB\": [],\n",
      "            \"ONARTUZUMAB\": [],\n",
      "            \"OLAPARIB\": [],\n",
      "            \"SERIBANTUMAB\": [],\n",
      "            \"RAMUCIRUMAB\": [],\n",
      "            \"AZD-8055\": [],\n",
      "            \"BENZONATATE\": [],\n",
      "            \"TIVOZANIB\": [],\n",
      "            \"AFATINIB DIMALEATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"OSIMERTINIB MESYLATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"Allitinib\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"JNJ-26483327\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MP-412\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"Hemay-022\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CANERTINIB DIHYDROCHLORIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DACOMITINIB HYDRATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ERTUMAXOMAB\": [],\n",
      "            \"MDX-210\": [],\n",
      "            \"VANDETANIB\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"FADS1\": {\n",
      "            \"LINOLENIC ACID\": [\n",
      "                \"ligand\"\n",
      "            ],\n",
      "            \"ICOSAPENT\": [\n",
      "                \"agonist\"\n",
      "            ]\n",
      "        },\n",
      "        \"GANAB\": {\n",
      "            \"MIGLITOL\": [\n",
      "                \"antagonist\"\n",
      "            ]\n",
      "        },\n",
      "        \"GLDC\": {\n",
      "            \"PYRIDOXAL PHOSPHATE\": [\n",
      "                \"cofactor\"\n",
      "            ],\n",
      "            \"GLYCINE\": []\n",
      "        },\n",
      "        \"GMPS\": {\n",
      "            \"L-GLUTAMATE\": []\n",
      "        },\n",
      "        \"HCK\": {\n",
      "            \"BOSUTINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"IBRUTINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL1081312\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL306380\": [],\n",
      "            \"CHEMBL286939\": [],\n",
      "            \"QUERCETIN\": [],\n",
      "            \"DASATINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ENMD-981693\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ILORASERTIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"XL-228\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TG100-801\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MASITINIB\": [],\n",
      "            \"NINTEDANIB\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"ILF3\": {\n",
      "            \"CYCLOSPORINE\": []\n",
      "        },\n",
      "        \"INHBA\": {\n",
      "            \"SOTATERCEPT\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"KDM2A\": {\n",
      "            \"CHEMBL2164243\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"KEAP1\": {\n",
      "            \"DIMETHYL FUMARATE\": [\n",
      "                \"inhibitor\",\n",
      "                \"binder\"\n",
      "            ],\n",
      "            \"BARDOXOLONE METHYL\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"KIF11\": {\n",
      "            \"CK0106023\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MONASTROL\": [],\n",
      "            \"CHEMBL205786\": [],\n",
      "            \"CHEMBL228369\": [],\n",
      "            \"CHEMBL481931\": [],\n",
      "            \"(R)-MON-97\": [],\n",
      "            \"CHEMBL205437\": [],\n",
      "            \"CHEMBL204459\": [],\n",
      "            \"CHEMBL380955\": [],\n",
      "            \"FILANESIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ISPINESIB (CHEMBL228814)\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LITRONESIB\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"KIF1A\": {\n",
      "            \"PHOSPHOMETHYLPHOSPHONIC ACID ADENYLATE ESTER\": [],\n",
      "            \"CHEMBL1230989\": []\n",
      "        },\n",
      "        \"KIF2C\": {\n",
      "            \"CHEMBL1230989\": []\n",
      "        },\n",
      "        \"KLC3\": {\n",
      "            \"PHENYLTHIOUREA\": [],\n",
      "            \"FLUOROURACIL\": [],\n",
      "            \"IFOSFAMIDE\": [],\n",
      "            \"OXALIPLATIN\": []\n",
      "        },\n",
      "        \"MED1\": {\n",
      "            \"BECOCALCIDIOL\": []\n",
      "        },\n",
      "        \"MSH2\": {\n",
      "            \"PEMBROLIZUMAB\": [],\n",
      "            \"NIVOLUMAB\": [],\n",
      "            \"IPILIMUMAB\": [],\n",
      "            \"ATEZOLIZUMAB\": [],\n",
      "            \"DURVALUMAB\": []\n",
      "        },\n",
      "        \"MSH6\": {\n",
      "            \"TEMOZOLOMIDE\": [],\n",
      "            \"PEMBROLIZUMAB\": [],\n",
      "            \"NIVOLUMAB\": [],\n",
      "            \"IPILIMUMAB\": [],\n",
      "            \"ATEZOLIZUMAB\": [],\n",
      "            \"DURVALUMAB\": []\n",
      "        },\n",
      "        \"MTHFD2\": {\n",
      "            \"TETRAHYDROFOLATE\": [\n",
      "                \"cofactor\"\n",
      "            ],\n",
      "            \"CHEMBL1161866\": []\n",
      "        },\n",
      "        \"MYO9B\": {\n",
      "            \"MANNOMUSTINE\": [],\n",
      "            \"CAFFEINE\": [],\n",
      "            \"CAPTOPRIL\": [],\n",
      "            \"DIBUCAINE\": [],\n",
      "            \"FELODIPINE\": [],\n",
      "            \"PROPYLTHIOURACIL\": [],\n",
      "            \"VOLANESORSEN SODIUM\": [],\n",
      "            \"STREPTOZOTOCIN\": [],\n",
      "            \"TESTOSTERONE\": [],\n",
      "            \"WORTMANNIN\": [],\n",
      "            \"NIFEDIPINE\": []\n",
      "        },\n",
      "        \"PAK2\": {\n",
      "            \"SELEGILINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"STAUROSPORINE\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"PARP1\": {\n",
      "            \"CHEMBL123904\": [],\n",
      "            \"NIACINAMIDE\": [\n",
      "                \"binder\"\n",
      "            ],\n",
      "            \"CHEMBL401843\": [],\n",
      "            \"CHEMBL123978\": [],\n",
      "            \"CHEMBL125200\": [],\n",
      "            \"CHEMBL134022\": [],\n",
      "            \"CHEMBL338790\": [],\n",
      "            \"VELIPARIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL452800\": [],\n",
      "            \"CHEMBL361054\": [],\n",
      "            \"OLAPARIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"RUCAPARIB\": [\n",
      "                \"inhibitor\",\n",
      "                \"antagonist\"\n",
      "            ],\n",
      "            \"NIRAPARIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"HEPTANOATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TALAZOPARIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"INOSINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"INIPARIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TALAZOPARIB TOSYLATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"RUCAPARIB CAMSYLATE\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"PDF\": {\n",
      "            \"CHEMBL431210\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"PRKCI\": {\n",
      "            \"CEP-2563\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"GF-109203\": [],\n",
      "            \"STAUROSPORINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"GSK-690693\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"(7S)-HYDROXYL-STAUROSPORINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"QUERCETIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MIDOSTAURIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"INGENOL MEBUTATE\": [],\n",
      "            \"SOTRASTAURIN\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"PRRC2A\": {\n",
      "            \"CARBAMAZEPINE\": []\n",
      "        },\n",
      "        \"SMARCA4\": {\n",
      "            \"TRETINOIN\": [],\n",
      "            \"VINORELBINE BASE\": []\n",
      "        },\n",
      "        \"SMARCA5\": {\n",
      "            \"DEXTROSE\": []\n",
      "        },\n",
      "        \"SMARCB1\": {\n",
      "            \"PANOBINOSTAT\": [],\n",
      "            \"PALBOCICLIB\": [],\n",
      "            \"ALVOCIDIB\": [],\n",
      "            \"FENRETINIDE\": [],\n",
      "            \"VORINOSTAT\": [],\n",
      "            \"PENTANAL\": []\n",
      "        },\n",
      "        \"STAT2\": {\n",
      "            \"ISOTRETINOIN\": []\n",
      "        },\n",
      "        \"THBS2\": {\n",
      "            \"CORTICOTROPIN\": [],\n",
      "            \"BEVACIZUMAB\": []\n",
      "        },\n",
      "        \"TK1\": {\n",
      "            \"THYMIDINE_TRIPHOSPHATE\": []\n",
      "        },\n",
      "        \"TNFSF10\": {\n",
      "            \"SODIUM BUTYRATE\": [],\n",
      "            \"TRICHOSTATIN\": []\n",
      "        },\n",
      "        \"TOP1\": {\n",
      "            \"CAMPTOTHECIN\": [],\n",
      "            \"EDOTECARIN\": [],\n",
      "            \"LUCANTHONE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ELSAMITRUCIN\": [],\n",
      "            \"7-ETHYL-10-HYDROXY-CAMPTOTHECIN\": [],\n",
      "            \"SODIUM STIBOGLUCONATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"KARENITECIN\": [],\n",
      "            \"CHEMBL343336\": [],\n",
      "            \"CAFFEINE\": [],\n",
      "            \"CYCLOPHOSPHAMIDE\": [],\n",
      "            \"BECATECARIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ETIRINOTECAN PEGOL\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"IRINOTECAN SUCROSOFATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LURTOTECAN\": [],\n",
      "            \"IRINOTECAN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TOPOTECAN\": [],\n",
      "            \"C-1311 (CHEMBL3545337)\": [],\n",
      "            \"RUBITECAN\": [],\n",
      "            \"IRINOTECAN HYDROCHLORIDE HYDRATE\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"TOP2A\": {\n",
      "            \"TENIPOSIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AMSACRINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"VALRUBICIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"EPIRUBICIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ENOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PEFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TROVAFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LOMEFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"NORFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LEVOFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"OFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PODOFILOX\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MITOXANTRONE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"SPARFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DOXORUBICIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ETOPOSIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"GENISTEIN\": [],\n",
      "            \"FLEROXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LUCANTHONE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"BANOXANTRONE\": [],\n",
      "            \"AMONAFIDE\": [],\n",
      "            \"ELSAMITRUCIN\": [],\n",
      "            \"BERUBICIN HYDROCHLORIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AMRUBICIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"FINAFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DAUNORUBICIN\": [],\n",
      "            \"DEXRAZOXANE\": [],\n",
      "            \"HYDROQUINONE\": [],\n",
      "            \"VINCRISTINE\": [],\n",
      "            \"VOSAROXIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AMRUBICIN HYDROCHLORIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ALDOXORUBICIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"BECATECARIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MM-302\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ETOPOSIDE PHOSPHATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DAUNORUBICIN CITRATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DAUNORUBICIN HYDROCHLORIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DOXORUBICIN HYDROCHLORIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MITOXANTRONE DIHYDROCHLORIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"IDARUBICIN\": [],\n",
      "            \"PACLITAXEL\": [],\n",
      "            \"C-1311 (CHEMBL3545337)\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DACTINOMYCIN\": [],\n",
      "            \"CAMPTOTHECIN\": [],\n",
      "            \"IDARUBICIN HYDROCHLORIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"IDRONOXIL\": []\n",
      "        },\n",
      "        \"TP53\": {\n",
      "            \"TARENFLURBIL\": [],\n",
      "            \"ASPIRIN\": [\n",
      "                \"acetylation\"\n",
      "            ],\n",
      "            \"Lesogaberan\": [],\n",
      "            \"CHEMBL1235116\": [],\n",
      "            \"DIETHYLSTILBESTROL\": [],\n",
      "            \"ENALAPRIL\": [],\n",
      "            \"RIZATRIPTAN\": [],\n",
      "            \"HALOPERIDOL\": [],\n",
      "            \"PROXYPHYLLINE\": [],\n",
      "            \"INOSITOL\": [],\n",
      "            \"INTERFERON ALFA-2B\": [],\n",
      "            \"CHEMBL1221512\": [],\n",
      "            \"METHIMAZOLE\": [],\n",
      "            \"METHYLPREDNISOLONE\": [],\n",
      "            \"MYCOPHENOLIC ACID\": [],\n",
      "            \"PACLITAXEL\": [],\n",
      "            \"PROPYLTHIOURACIL\": [],\n",
      "            \"PUROMYCIN\": [],\n",
      "            \"SIROLIMUS\": [],\n",
      "            \"RITUXIMAB\": [],\n",
      "            \"STREPTONIGRIN\": [],\n",
      "            \"TIRAPAZAMINE\": [],\n",
      "            \"THIOTEPA\": [],\n",
      "            \"TRIFLUOPERAZINE\": [],\n",
      "            \"URSODIOL\": [],\n",
      "            \"BEVACIZUMAB\": [],\n",
      "            \"VESNARINONE\": [],\n",
      "            \"YONDELIS\": [],\n",
      "            \"FLUOROURACIL\": [],\n",
      "            \"GARLIC\": [],\n",
      "            \"GOSSYPOL\": [],\n",
      "            \"GRANISETRON\": [],\n",
      "            \"ZINC CHLORIDE\": [],\n",
      "            \"BORTEZOMIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ABEMACICLIB\": [],\n",
      "            \"AZD-6738\": [],\n",
      "            \"DECITABINE\": [],\n",
      "            \"DOXORUBICIN\": [],\n",
      "            \"GEMCITABINE\": [],\n",
      "            \"MITOMYCIN\": [],\n",
      "            \"AZD-1775\": [],\n",
      "            \"PRAMLINTIDE\": [],\n",
      "            \"DOCETAXEL\": [],\n",
      "            \"SELUMETINIB\": [],\n",
      "            \"TAMOXIFEN\": [],\n",
      "            \"OXALIPLATIN\": [],\n",
      "            \"CETUXIMAB\": [],\n",
      "            \"CAPECITABINE\": [],\n",
      "            \"CARBOPLATIN\": [],\n",
      "            \"GANETESPIB\": [],\n",
      "            \"SELICICLIB\": [],\n",
      "            \"Tepotinib\": [],\n",
      "            \"CRIZOTINIB\": [],\n",
      "            \"CYCLOPHOSPHAMIDE\": [],\n",
      "            \"TOPOTECAN\": [],\n",
      "            \"DASATINIB\": [],\n",
      "            \"DEMCIZUMAB\": [],\n",
      "            \"INK-128\": [],\n",
      "            \"PD-0325901\": [],\n",
      "            \"VX-970\": [],\n",
      "            \"EPIRUBICIN\": [],\n",
      "            \"GEDATOLISIB\": [],\n",
      "            \"ENCORAFENIB\": [],\n",
      "            \"NAVITOCLAX\": [],\n",
      "            \"DABRAFENIB\": [],\n",
      "            \"PF-04217903\": [],\n",
      "            \"DACTOLISIB\": [],\n",
      "            \"IRINOTECAN\": [],\n",
      "            \"CHEMBL376408\": [],\n",
      "            \"ALPELISIB\": [],\n",
      "            \"TRAMETINIB\": [],\n",
      "            \"CYTARABINE\": [],\n",
      "            \"NUTLIN-3\": [],\n",
      "            \"PAZOPANIB\": [],\n",
      "            \"VORINOSTAT\": [],\n",
      "            \"HEMICHOLINIUM-3\": [],\n",
      "            \"PF-00477736\": [],\n",
      "            \"PRODIGIOSIN\": [],\n",
      "            \"TRIFLURIDINE\": [],\n",
      "            \"RG-547\": [],\n",
      "            \"LY-3009120\": [],\n",
      "            \"VEMURAFENIB\": [],\n",
      "            \"DAUNORUBICIN\": [],\n",
      "            \"IFOSFAMIDE\": [],\n",
      "            \"DS-7423\": [],\n",
      "            \"LORLATINIB\": [],\n",
      "            \"SP-600125\": [],\n",
      "            \"PHA-680632\": [],\n",
      "            \"OLAPARIB\": [],\n",
      "            \"AZD-5363\": [],\n",
      "            \"CAPMATINIB\": [],\n",
      "            \"AMG-337\": [],\n",
      "            \"TANESPIMYCIN\": [],\n",
      "            \"PANITUMUMAB\": [],\n",
      "            \"AMG-900\": [],\n",
      "            \"AZD-6482\": [],\n",
      "            \"IBRUTINIB\": [],\n",
      "            \"ALVESPIMYCIN\": [],\n",
      "            \"PIMASERTIB\": [],\n",
      "            \"CHEMBL303958\": [],\n",
      "            \"TEMOZOLOMIDE\": [],\n",
      "            \"RG-7602\": [],\n",
      "            \"ETOPOSIDE\": [],\n",
      "            \"PEMBROLIZUMAB\": [],\n",
      "            \"DUVELISIB\": [],\n",
      "            \"AZD-7762\": [],\n",
      "            \"ERLOTINIB\": [],\n",
      "            \"CHEMBL392068\": []\n",
      "        },\n",
      "        \"TPX2\": {\n",
      "            \"N (g)-NITRO-L-ARGININE\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"TUBB4A\": {\n",
      "            \"EPOTHILONE D\": [],\n",
      "            \"PATUPILONE\": [],\n",
      "            \"LEXIBULIN\": []\n",
      "        },\n",
      "        \"VCAM1\": {\n",
      "            \"CARVEDILOL\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"SUCCINOBUCOL\": [],\n",
      "            \"DEXAMETHASONE\": [],\n",
      "            \"PHORBOL MYRISTATE ACETATE\": [],\n",
      "            \"TROGLITAZONE\": [],\n",
      "            \"MERCAPTOPURINE\": [],\n",
      "            \"CYCLOSPORINE\": []\n",
      "        },\n",
      "        \"WNT7A\": {\n",
      "            \"DIETHYLSTILBESTROL\": []\n",
      "        },\n",
      "        \"XPO1\": {\n",
      "            \"SELINEXOR\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        }\n",
      "    },\n",
      "    \"LVSI_1.0\": {\n",
      "        \"GLDC\": {\n",
      "            \"PYRIDOXAL PHOSPHATE\": [\n",
      "                \"cofactor\"\n",
      "            ],\n",
      "            \"GLYCINE\": []\n",
      "        },\n",
      "        \"HAPLN1\": {\n",
      "            \"HYALURONIC ACID\": [\n",
      "                \"binder\"\n",
      "            ]\n",
      "        },\n",
      "        \"PRRC2A\": {\n",
      "            \"CARBAMAZEPINE\": []\n",
      "        }\n",
      "    }\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "}\n"
     ]
    }
   ],
   "source": [
    "print('UP-REGULATED INHIBITORS:\\n')\n",
    "inhibitor_dict = {}\n",
    "for i, request in enumerate(requests_up):\n",
    "    clinical_attribute = sig_cols[i].columns[0][:-9]\n",
    "    inhibitor_dict[clinical_attribute] = bf.dgidb_json_parse(request, genes=True)\n",
    "print(json.dumps(inhibitor_dict, indent=4))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Step 7b: Compare patients' significant genes with the drugs they are currently taking"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['Patient_ID',\n",
       " 'Proteomics_Tumor_Normal',\n",
       " 'Country',\n",
       " 'Histologic_Grade_FIGO',\n",
       " 'Myometrial_invasion_Specify',\n",
       " 'Histologic_type',\n",
       " 'Treatment_naive',\n",
       " 'Tumor_purity',\n",
       " 'Path_Stage_Primary_Tumor-pT',\n",
       " 'Path_Stage_Reg_Lymph_Nodes-pN',\n",
       " 'Clin_Stage_Dist_Mets-cM',\n",
       " 'Path_Stage_Dist_Mets-pM',\n",
       " 'tumor_Stage-Pathological',\n",
       " 'FIGO_stage',\n",
       " 'LVSI',\n",
       " 'BMI',\n",
       " 'Age',\n",
       " 'Diabetes',\n",
       " 'Race',\n",
       " 'Ethnicity',\n",
       " 'Gender',\n",
       " 'Tumor_Site',\n",
       " 'Tumor_Site_Other',\n",
       " 'Tumor_Focality',\n",
       " 'Tumor_Size_cm',\n",
       " 'Num_full_term_pregnancies',\n",
       " 'MSI_status',\n",
       " 'Genomics_subtype']"
      ]
     },
     "execution_count": 36,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "list(clinical.columns)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "\"\\nThis cell is not working because I need to still connect the drugs that patients\\nare taking with the clinical dataframe somehow. I'll need to merge dataframes\\nmost likely.  Additionally, I will probably need to rework my function to include\\nan arg for medication_col_name or something like that to work on multiple datasets\\nand not just for Renal\\n\""
      ]
     },
     "execution_count": 37,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "'''\n",
    "This cell is not working because I need to still connect the drugs that patients\n",
    "are taking with the clinical dataframe somehow. I'll need to merge dataframes\n",
    "most likely.  Additionally, I will probably need to rework my function to include\n",
    "an arg for medication_col_name or something like that to work on multiple datasets\n",
    "and not just for Renal\n",
    "'''\n",
    "#patient_drugs_genes_up = bf.compare_enrichments_with_drugs(outlier_up_prot_dict, clinical)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "follow_up_df = pd.read_excel('CPTAC3_Uterine_FollowUp_Outcome_8_12.xlsx')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0     NaN\n",
       "1     NaN\n",
       "2     NaN\n",
       "3     NaN\n",
       "4     NaN\n",
       "5     NaN\n",
       "6     NaN\n",
       "7     NaN\n",
       "8     NaN\n",
       "9     NaN\n",
       "10    NaN\n",
       "11    NaN\n",
       "12    NaN\n",
       "13    NaN\n",
       "14    NaN\n",
       "15    NaN\n",
       "16    NaN\n",
       "17    NaN\n",
       "18    NaN\n",
       "19    NaN\n",
       "20    NaN\n",
       "21    NaN\n",
       "22    NaN\n",
       "23    NaN\n",
       "24    NaN\n",
       "25    NaN\n",
       "26    NaN\n",
       "27    NaN\n",
       "28    NaN\n",
       "29    NaN\n",
       "       ..\n",
       "365   NaN\n",
       "366   NaN\n",
       "367   NaN\n",
       "368   NaN\n",
       "369   NaN\n",
       "370   NaN\n",
       "371   NaN\n",
       "372   NaN\n",
       "373   NaN\n",
       "374   NaN\n",
       "375   NaN\n",
       "376   NaN\n",
       "377   NaN\n",
       "378   NaN\n",
       "379   NaN\n",
       "380   NaN\n",
       "381   NaN\n",
       "382   NaN\n",
       "383   NaN\n",
       "384   NaN\n",
       "385   NaN\n",
       "386   NaN\n",
       "387   NaN\n",
       "388   NaN\n",
       "389   NaN\n",
       "390   NaN\n",
       "391   NaN\n",
       "392   NaN\n",
       "393   NaN\n",
       "394   NaN\n",
       "Name: Other New Tumor Procedure, Length: 395, dtype: float64"
      ]
     },
     "execution_count": 39,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "follow_up_df['Other New Tumor Procedure']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "living_filter = follow_up_df['Vital Status'] == 'Living'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "living_follow_up = follow_up_df[living_filter]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "deceased_follow_up = follow_up_df[~living_filter]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Case ID                                                           C3L-02894\n",
       "Follow-up Period                                                  12 Months\n",
       "Lost to Follow-up?                                                       No\n",
       "Vital Status                                                       Deceased\n",
       "Path Diag to Last Contact(Day)                                          428\n",
       "Cause of Death                                                          NaN\n",
       "Path Diag to Death(days)                                                431\n",
       "Adj Post-Op Radiation Therapy                                           Yes\n",
       "Adj Post-Op Pharma Therapy                                              Yes\n",
       "Adj Post-Op Immunotherapy                                                No\n",
       "Tumor Status                                                     With Tumor\n",
       "Menopausal Hormone Therapy                                          Unknown\n",
       "Oral Contraceptives                                                 Unknown\n",
       "Tamoxifen                                                           Unknown\n",
       "Hypertension                                                             No\n",
       "Diabetes                                                                 No\n",
       "Num Full Pregnancies                                                   None\n",
       "Colorectal Cancer                                                        No\n",
       "Success of Initial Treatment                             Persistent Disease\n",
       "Success of Treatment@ Followup                             Patient Deceased\n",
       "ECOG Score                         Not Evaluated: Not provided or available\n",
       "Karnofsky Score                    Not Evaluated: Not provided or available\n",
       "Perform Status Scale: Timing      Not Evaluated: Not provided or available.\n",
       "Other Perform Scale Timing                                              NaN\n",
       "New Tumor After Initial TRT                                              No\n",
       "Locoregional Recurrence Tumor                                           NaN\n",
       "Distant Metastasis Tumor                                                NaN\n",
       "New Primary Tumor                                                       NaN\n",
       "New Tumor Site Unknown                                                  NaN\n",
       "New Tumor Site Lung                                                     NaN\n",
       "New Tumor Site Bone                                                     NaN\n",
       "New Tumor Site Liver                                                    NaN\n",
       "New Tumor Site Brain                                                    NaN\n",
       "New Tumor Site Other                                                    NaN\n",
       "Specify Other New Tumor Site                                            NaN\n",
       "Path Diag to new Tumor (days)                                           NaN\n",
       "Additional Surgery ?                                                    NaN\n",
       "Path Diag to Surgery (days)                                             NaN\n",
       "New Tumor Procedure Unknown                                             NaN\n",
       "New Tumor Excisional biopsy                                             NaN\n",
       "New Tumor Incisional biopsy                                             NaN\n",
       "New Tumor Surgical Resection                                            NaN\n",
       "Other New Tumor Procedure                                               NaN\n",
       "Specify Other New Tumor Proc                                            NaN\n",
       "Residual Tumor After Surgery                                            NaN\n",
       "Radiation for New Tumor                                                 NaN\n",
       "Pharmaceutical for New Tumor                                            NaN\n",
       "Immunological for New Tumor                                             NaN\n",
       "Name: 209, dtype: object"
      ]
     },
     "execution_count": 43,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "deceased_follow_up.iloc[3]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "persistent_filter = follow_up_df['Success of Initial Treatment'] == 'Persistent Disease'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "persistent_disease = follow_up_df[persistent_filter]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "df = pd.read_csv('https://raw.githubusercontent.com/ruggleslab/blacksheep_supp/dev/vignettes/brca/phospho_common_samples_data.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "other = pd.read_csv('https://raw.githubusercontent.com/ruggleslab/blacksheep_supp/dev/vignettes/brca/annotations_common_samples.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(76, 24)"
      ]
     },
     "execution_count": 52,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.6.2"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
